MLK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T362 | Sugiyama | ACTN4 | HKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKMVSD |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T28 | Sugiyama | CAT | ASDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRG |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S25 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KVGVNGFGRIGRLVtRAAFNsGKVDIVAINDPFIDLNyMVY |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T153 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | MGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEG |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T19 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | __MGKVKVGVNGFGRIGRLVtRAAFNsGKVDIVAINDPFID |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S439 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | NIVIAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNG |
| P07237 | T442 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | IAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERt |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T495 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRKHG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08708 | T102 | Sugiyama | RPS17 RPS17L | DNyVPEVsALDQEIIEVDPDtKEMLKLLDFGsLsNLQVtQP |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09132 | S69 | Sugiyama | SRP19 | IQDVCSAVGLNVFLEKNKMYsREWNRDVQYRGRVRVQLKQE |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09661 | T213 | Sugiyama | SNRPA1 | KGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGRE |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P10412 | S41 | Sugiyama | H1-4 H1F4 HIST1H1E | KKKARKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | T45 | Sugiyama | H1-4 H1F4 HIST1H1E | RKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P10809 | T428 | Sugiyama | HSPD1 HSP60 | GtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGCALLRCI |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T425 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TAGGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEG |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T343 | Sugiyama | ACTN1 | HKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRMVSD |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S578 | Sugiyama | EEF2 EF2 | LKDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNK |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13688 | S508 | EPSD | CEACAM1 BGP BGP1 | MNEVtysTLNFEAQQPTQPTsASPsLTATEIIySEVKKQ__ |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T454 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SGRSAHQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLC |
| P14618 | T459 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | HQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLCKDPVQ |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T675 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P14649 | T101 | Sugiyama | MYL6B MLC1SA | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDELKSRR |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S206 | Sugiyama | RPS2 RPS4 | GRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDCytsA |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15923 | S341 | SIGNOR|EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | RGTTAGSsGDALGKALAsIysPDHssNNFsssPstPVGsPQ |
| P15923 | S352 | SIGNOR|EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | LGKALAsIysPDHssNNFsssPstPVGsPQGLAGTSQWPRA |
| P15923 | S359 | SIGNOR|EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | IysPDHssNNFsssPstPVGsPQGLAGTSQWPRAGAPGALs |
| P15923 | S379 | SIGNOR|EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | sPQGLAGTSQWPRAGAPGALsPsYDGGLHGLQsKIEDHLDE |
| P15923 | T355 | SIGNOR|EPSD|PSP | TCF3 BHLHB21 E2A ITF1 | ALAsIysPDHssNNFsssPstPVGsPQGLAGTSQWPRAGAP |
| P16402 | S42 | Sugiyama | H1-3 H1F3 HIST1H1D | KKAKKAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | T46 | Sugiyama | H1-3 H1F3 HIST1H1D | KAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16403 | S41 | Sugiyama | H1-2 H1F2 HIST1H1C | KKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | T45 | Sugiyama | H1-2 H1F2 HIST1H1C | AKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18077 | S90 | Sugiyama | RPL35A GIG33 | IWGKVTRAHGNSGMVRAKFRsNLPAKAIGHRIRVMLyPSRI |
| P18621 | S14 | Sugiyama | RPL17 | _______MVRysLDPENPtKsCKSRGSNLRVHFKNtRETAQ |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P22314 | S56 | Sugiyama | UBA1 A1S9T UBE1 | VPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVL |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | T26 | Sugiyama | RPS3 OK/SW-cl.26 | sKKRKFVADGIFKAELNEFLtRELAEDGysGVEVRVtPTRT |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P25205 | S34 | Sugiyama | MCM3 | EAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVNDL |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S536 | Sugiyama | MSN | ERVQKHLKALtsELANARDEsKKTANDMIHAENMRLGRDKY |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | T30 | Sugiyama | YWHAQ | AKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKN |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P29692 | T73 | Sugiyama | EEF1D EF1D | ARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQs |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30041 | T192 | Sugiyama | PRDX6 AOP2 KIAA0106 | EKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGVFtKELP |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30041 | T95 | Sugiyama | PRDX6 AOP2 KIAA0106 | SVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRELAILLG |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30085 | S180 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | KPIIDLyEEMGKVKKIDASKsVDEVFDEVVQIFDKEG____ |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | S478 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKK |
| P30101 | T437 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KELGEKLsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsP |
| P30419 | T134 | Sugiyama | NMT1 NMT | KRSyQFWDtQPVPKLGEVVNtHGPVEPDKDNIRQEPYTLPQ |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | T32 | Sugiyama | YWHAB | AKLAEQAERyDDMAAAMKAVtEQGHELsNEERNLLsVAyKN |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31948 | S28 | Sugiyama | STIP1 | KEKGNKALsVGNIDDALQCysEAIKLDPHNHVLysNRsAAy |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33176 | S443 | Sugiyama | KIF5B KNS KNS1 | EEIAKLYKQLDDKDEEINQQsQLVEKLKTQMLDQEELLAST |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P34897 | S76 | Sugiyama | SHMT2 | MWELLQREKDRQCRGLELIAsENFCsRAALEALGsCLNNKY |
| P34897 | S81 | Sugiyama | SHMT2 | QREKDRQCRGLELIAsENFCsRAALEALGsCLNNKYSEGYP |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35609 | T350 | Sugiyama | ACTN2 | HKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKMVSD |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | S6 | Sugiyama | SRP14 | _______________MVLLEsEQFLtELTRLFQKCRTSGsV |
| P37108 | T11 | Sugiyama | SRP14 | __________MVLLEsEQFLtELTRLFQKCRTSGsVyItLK |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | S212 | Sugiyama | CCT3 CCTG TRIC5 | EIDIKKYARVEKIPGGIIEDsCVLRGVMINKDVTHPRMRRY |
| P50395 | S401 | Sugiyama | GDI2 RABGDIB | VsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIY |
| P50395 | T407 | Sugiyama | GDI2 RABGDIB | LVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGs |
| P50395 | T412 | Sugiyama | GDI2 RABGDIB | LGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFE |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50897 | T265 | Sugiyama | PPT1 CLN1 PPT | GFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLAT |
| P50990 | T286 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | MNFsKGEENLMDAQVKAIADtGANVVVtGGKVADMALHYAN |
| P50990 | T293 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ENLMDAQVKAIADtGANVVVtGGKVADMALHYANKYNIMLV |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60660 | T44 | Sugiyama | MYL6 | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDEMNVKV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61978 | S81 | Sugiyama | HNRNPK HNRPK | GGKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEIL |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62318 | T19 | Sugiyama | SNRPD3 | __MSIGVPIKVLHEAEGHIVtCEtNTGEVYRGKLIEAEDNM |
| P62318 | T22 | Sugiyama | SNRPD3 | SIGVPIKVLHEAEGHIVtCEtNTGEVYRGKLIEAEDNMNCQ |
| P62701 | T177 | Sugiyama | RPS4X CCG2 RPS4 SCAR | NDtIQIDLEtGKITDFIKFDtGNLCMVtGGANLGRIGVITN |
| P62701 | T184 | Sugiyama | RPS4X CCG2 RPS4 SCAR | LEtGKITDFIKFDtGNLCMVtGGANLGRIGVITNRERHPGs |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78371 | T246 | Sugiyama | CCT2 99D8.1 CCTB | VNQPKRIENAKILIANtGMDtDKIKIFGsRVRVDstAKVAE |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | T1386 | Sugiyama | SPTBN1 SPTB2 | ESTTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSD |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | S63 | Sugiyama | SET | EAIEHIDEVQNEIDRLNEQAsEEILKVEQKYNKLRQPFFQK |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02779 | T138 | Sugiyama | MAP3K10 MLK2 MST | RGEEVAVKAARLDPEKDPAVtAEQVCQEARLFGALQHPNII |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07021 | S87 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | CGCGCGSLHTDGDKAFVDFLsDEIKEERKIQKHKTLPKMsG |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q08043 | T357 | Sugiyama | ACTN3 | HKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKLVSD |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q12874 | S76 | Sugiyama | SF3A3 SAP61 | NLRDLyDDKDGLRKEELNAIsGPNEFAEFyNRLKQIKEFHR |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14247 | S117 | Sugiyama | CTTN EMS1 | KsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVDQsAV |
| Q14257 | T297 | Sugiyama | RCN2 ERC55 | LNGDKKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL |
| Q14444 | S97 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | DYQERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFM |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T101 | Sugiyama | RCN1 RCN | KERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNVA |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15459 | T124 | Sugiyama | SF3A1 SAP114 | GKAQEPSAAIPKVMQQQQQTtQQQLPQKVQAQVIQETIVPK |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7Z4S6 | S708 | Sugiyama | KIF21A KIAA1708 KIF2 | KIRDTQLERDQVLQNLGsVEsysEEKAKKVRSEYEKKLQAM |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WVJ2 | S142 | Sugiyama | NUDCD2 | LTLERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK_____ |
| Q92630 | S449 | EPSD|PSP | DYRK2 | DQLACMIELLGMPsQKLLDAsKRAKNFVSSKGYPRYCTVtt |
| Q92630 | T381 | EPSD|PSP | DYRK2 | RSGIKVIDFGSSCYEHQRVYtyIQSRFYRAPEVILGARYGM |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99832 | T300 | Sugiyama | CCT7 CCTH NIP7-1 | KIHHSGAKVVLSKLPIGDVAtQyFADRDMFCAGRVPEEDLK |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BXP5 | T702 | Sugiyama | SRRT ARS2 ASR2 | EEEAQKMGRKDPEQEVEKFVtsNtQELGKDKWLCPLsGKKF |
| Q9BXP5 | T705 | Sugiyama | SRRT ARS2 ASR2 | AQKMGRKDPEQEVEKFVtsNtQELGKDKWLCPLsGKKFKGP |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H788 | T142 | Sugiyama | SH2D4A PPP1R38 SH2A | TNsLKTKsQyHDLQAPDNQQtKDIWKKVAEKEELEQGsRPA |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NYF8 | T208 | Sugiyama | BCLAF1 BTF KIAA0164 | KDtFEHDPsEsIDEFNKssAtsGDIWPGLsAyDNsPRsPHs |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UMX5 | T130 | Sugiyama | NENF CIR2 SPUF | LTHDTTGLTAKELEALDEVFtKVYKAKYPIVGYTARRILNE |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPQ0 | S207 | Sugiyama | LIMCH1 KIAA1102 | RsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssD |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S74 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | GsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGE |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 4.773959e-15 | 14.321 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.558753e-13 | 12.807 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.357195e-09 | 8.628 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.019344e-08 | 7.992 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.663929e-09 | 8.015 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.120165e-08 | 7.951 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.419971e-08 | 7.848 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.936537e-08 | 7.713 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.869492e-08 | 7.104 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.586236e-08 | 7.120 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.832292e-07 | 6.737 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.696780e-07 | 6.174 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.696780e-07 | 6.174 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.804932e-07 | 6.009 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.597113e-06 | 5.586 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.597113e-06 | 5.586 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.423949e-06 | 5.465 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.613039e-06 | 5.442 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.075239e-06 | 5.390 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.355285e-06 | 5.271 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.565602e-06 | 5.254 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.900181e-06 | 5.161 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.586224e-06 | 5.066 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.817420e-05 | 4.741 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.854743e-05 | 4.732 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.176959e-05 | 4.662 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.640842e-05 | 4.578 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.912426e-05 | 4.536 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.051026e-05 | 4.516 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.945003e-05 | 4.404 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.060609e-05 | 4.296 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.531519e-05 | 4.257 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.471524e-05 | 4.189 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.036633e-05 | 4.153 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.505914e-05 | 4.070 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.802684e-05 | 4.009 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.109296e-04 | 3.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.141833e-04 | 3.942 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.587055e-04 | 3.799 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.786117e-04 | 3.748 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.799572e-04 | 3.745 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.956168e-04 | 3.709 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.244188e-04 | 3.649 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.277027e-04 | 3.643 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.618397e-04 | 3.582 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.705463e-04 | 3.568 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.764357e-04 | 3.558 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.995002e-04 | 3.524 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.404940e-04 | 3.468 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.842080e-04 | 3.415 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.000836e-04 | 3.398 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.119052e-04 | 3.385 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.142764e-04 | 3.383 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.333721e-04 | 3.363 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.680688e-04 | 3.330 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.924996e-04 | 3.308 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.077539e-04 | 3.294 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.200821e-04 | 3.284 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.285748e-04 | 3.277 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.909398e-04 | 3.228 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.909398e-04 | 3.228 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.944658e-04 | 3.226 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.959383e-04 | 3.225 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.051668e-04 | 3.218 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.340727e-04 | 3.198 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.359132e-04 | 3.197 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.591864e-04 | 3.181 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.899116e-04 | 3.161 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.884814e-04 | 3.162 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.910429e-04 | 3.160 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.910429e-04 | 3.160 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.064582e-04 | 3.151 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.828377e-04 | 3.106 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.828377e-04 | 3.106 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.428911e-04 | 3.074 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.956977e-04 | 3.048 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.956977e-04 | 3.048 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.683538e-04 | 3.061 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.203462e-04 | 3.036 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.367749e-04 | 3.028 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.057986e-03 | 2.976 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.095850e-03 | 2.960 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.087412e-03 | 2.964 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.045220e-03 | 2.981 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.087412e-03 | 2.964 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.065003e-03 | 2.973 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.128663e-03 | 2.947 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.128663e-03 | 2.947 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.047959e-03 | 2.980 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.087412e-03 | 2.964 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.045220e-03 | 2.981 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.035503e-03 | 2.985 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.146858e-03 | 2.940 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.185182e-03 | 2.926 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.209249e-03 | 2.917 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.185182e-03 | 2.926 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.234843e-03 | 2.908 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.202659e-03 | 2.920 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.318473e-03 | 2.880 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.377670e-03 | 2.861 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.431228e-03 | 2.844 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.470646e-03 | 2.832 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.475350e-03 | 2.831 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.496653e-03 | 2.825 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.515943e-03 | 2.819 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.566087e-03 | 2.805 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.593169e-03 | 2.798 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.711334e-03 | 2.767 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.711334e-03 | 2.767 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.643724e-03 | 2.784 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.643724e-03 | 2.784 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.601444e-03 | 2.795 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.782956e-03 | 2.749 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.782956e-03 | 2.749 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.790318e-03 | 2.747 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.812767e-03 | 2.742 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.835580e-03 | 2.736 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.835580e-03 | 2.736 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.999691e-03 | 2.699 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.186118e-03 | 2.660 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.254262e-03 | 2.647 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.264614e-03 | 2.645 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.293229e-03 | 2.640 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.448927e-03 | 2.611 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.529853e-03 | 2.597 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.755074e-03 | 2.560 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.755074e-03 | 2.560 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.693459e-03 | 2.570 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.792888e-03 | 2.554 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.587112e-03 | 2.587 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.611931e-03 | 2.583 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.842480e-03 | 2.546 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.842480e-03 | 2.546 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.955567e-03 | 2.529 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.027437e-03 | 2.519 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.158854e-03 | 2.500 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.333864e-03 | 2.477 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.515504e-03 | 2.454 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.529359e-03 | 2.452 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.666018e-03 | 2.436 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.529359e-03 | 2.452 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.515504e-03 | 2.454 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.676771e-03 | 2.435 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.001593e-03 | 2.398 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.010500e-03 | 2.397 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.239326e-03 | 2.373 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.384580e-03 | 2.358 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.384580e-03 | 2.358 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.402238e-03 | 2.356 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.402238e-03 | 2.356 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.418080e-03 | 2.355 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.000420e-03 | 2.301 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.000420e-03 | 2.301 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.000420e-03 | 2.301 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.000420e-03 | 2.301 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.125801e-03 | 2.290 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.788751e-03 | 2.320 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.000420e-03 | 2.301 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.180118e-03 | 2.286 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.180118e-03 | 2.286 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.295332e-03 | 2.276 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.324999e-03 | 2.274 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.455484e-03 | 2.263 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.561558e-03 | 2.255 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.706239e-03 | 2.244 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.898525e-03 | 2.229 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.923787e-03 | 2.227 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.973668e-03 | 2.224 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.010301e-03 | 2.221 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.355689e-03 | 2.197 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.400369e-03 | 2.194 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.467617e-03 | 2.189 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.467617e-03 | 2.189 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.758719e-03 | 2.170 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.913335e-03 | 2.160 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.094241e-03 | 2.149 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.569867e-03 | 2.182 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.121268e-03 | 2.147 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.338814e-03 | 2.134 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.433421e-03 | 2.129 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.472566e-03 | 2.127 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.800107e-03 | 2.108 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.801186e-03 | 2.108 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.085344e-03 | 2.092 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.085344e-03 | 2.092 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.420674e-03 | 2.075 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.677082e-03 | 2.062 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.785719e-03 | 2.056 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.891895e-03 | 2.051 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.023705e-02 | 1.990 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.019941e-02 | 1.991 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.012217e-02 | 1.995 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.343715e-03 | 2.029 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.343715e-03 | 2.029 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.343715e-03 | 2.029 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.576609e-03 | 2.019 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.765689e-03 | 2.010 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.761382e-03 | 2.010 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.765689e-03 | 2.010 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.310183e-03 | 2.031 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.051878e-02 | 1.978 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.053936e-02 | 1.977 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.115534e-02 | 1.953 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.125343e-02 | 1.949 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.153927e-02 | 1.938 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.155002e-02 | 1.937 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.187156e-02 | 1.925 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.219231e-02 | 1.914 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.220883e-02 | 1.913 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.223491e-02 | 1.912 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.223913e-02 | 1.912 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.226150e-02 | 1.911 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.257902e-02 | 1.900 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.315324e-02 | 1.881 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.351561e-02 | 1.869 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.360185e-02 | 1.866 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.381260e-02 | 1.860 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.381260e-02 | 1.860 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.381260e-02 | 1.860 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.392791e-02 | 1.856 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.594577e-02 | 1.797 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.594577e-02 | 1.797 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.430235e-02 | 1.845 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.491635e-02 | 1.826 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.536264e-02 | 1.814 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.536264e-02 | 1.814 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.430235e-02 | 1.845 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.447548e-02 | 1.839 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.594577e-02 | 1.797 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.546163e-02 | 1.811 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.546510e-02 | 1.811 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.567026e-02 | 1.805 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.618105e-02 | 1.791 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.618105e-02 | 1.791 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.627616e-02 | 1.788 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.627616e-02 | 1.788 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.627616e-02 | 1.788 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.642247e-02 | 1.785 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.647098e-02 | 1.783 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.651373e-02 | 1.782 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.717120e-02 | 1.765 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.867369e-02 | 1.729 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.867369e-02 | 1.729 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.867369e-02 | 1.729 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.889270e-02 | 1.724 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.889270e-02 | 1.724 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.889270e-02 | 1.724 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.889270e-02 | 1.724 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.889270e-02 | 1.724 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.889270e-02 | 1.724 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.025218e-02 | 1.694 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.025218e-02 | 1.694 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.932971e-02 | 1.714 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.935610e-02 | 1.713 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.935610e-02 | 1.713 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.807957e-02 | 1.743 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.916660e-02 | 1.717 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.916660e-02 | 1.717 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.768100e-02 | 1.752 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.768100e-02 | 1.752 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.924884e-02 | 1.716 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.025218e-02 | 1.694 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.932971e-02 | 1.714 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.963420e-02 | 1.707 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.889270e-02 | 1.724 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.889270e-02 | 1.724 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.865859e-02 | 1.729 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.869473e-02 | 1.728 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.058046e-02 | 1.687 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.058346e-02 | 1.686 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.071200e-02 | 1.684 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.090444e-02 | 1.680 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.196126e-02 | 1.658 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.211413e-02 | 1.655 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.211413e-02 | 1.655 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.215891e-02 | 1.654 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.260982e-02 | 1.646 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.283632e-02 | 1.641 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.283632e-02 | 1.641 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.327102e-02 | 1.633 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.374730e-02 | 1.624 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.382381e-02 | 1.623 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.434299e-02 | 1.614 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.437961e-02 | 1.613 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.437961e-02 | 1.613 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.459336e-02 | 1.609 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.459336e-02 | 1.609 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.983074e-02 | 1.525 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.983074e-02 | 1.525 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.983074e-02 | 1.525 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.983074e-02 | 1.525 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.701835e-02 | 1.568 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.701835e-02 | 1.568 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.515512e-02 | 1.599 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.595763e-02 | 1.586 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.595763e-02 | 1.586 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.595763e-02 | 1.586 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.595763e-02 | 1.586 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.595763e-02 | 1.586 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.931755e-02 | 1.533 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.625830e-02 | 1.581 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.578138e-02 | 1.589 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.661630e-02 | 1.575 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.595763e-02 | 1.586 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.515512e-02 | 1.599 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.578138e-02 | 1.589 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.833558e-02 | 1.548 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.633668e-02 | 1.579 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.812019e-02 | 1.551 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.661630e-02 | 1.575 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.032702e-02 | 1.518 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.032702e-02 | 1.518 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.032702e-02 | 1.518 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.045927e-02 | 1.516 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.045927e-02 | 1.516 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.046821e-02 | 1.516 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.111953e-02 | 1.507 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.111953e-02 | 1.507 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.111953e-02 | 1.507 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.111953e-02 | 1.507 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.111953e-02 | 1.507 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.173017e-02 | 1.499 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.207877e-02 | 1.494 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.268913e-02 | 1.486 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.268913e-02 | 1.486 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.268913e-02 | 1.486 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.270686e-02 | 1.485 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.282358e-02 | 1.484 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.282358e-02 | 1.484 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.284411e-02 | 1.484 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.284411e-02 | 1.484 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.284411e-02 | 1.484 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.327840e-02 | 1.478 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.484045e-02 | 1.458 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.510005e-02 | 1.455 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.551904e-02 | 1.450 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.712303e-02 | 1.430 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.768750e-02 | 1.424 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.787538e-02 | 1.422 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.815425e-02 | 1.418 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.913420e-02 | 1.407 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 4.423495e-02 | 1.354 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.423495e-02 | 1.354 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.423495e-02 | 1.354 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.423495e-02 | 1.354 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 4.423495e-02 | 1.354 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 4.423495e-02 | 1.354 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.423495e-02 | 1.354 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.423495e-02 | 1.354 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.423495e-02 | 1.354 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.579007e-02 | 1.339 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.579007e-02 | 1.339 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.115000e-02 | 1.386 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.163673e-02 | 1.381 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.163673e-02 | 1.381 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.717440e-02 | 1.326 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.126470e-02 | 1.384 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.126470e-02 | 1.384 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.463687e-02 | 1.350 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.529271e-02 | 1.344 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.270410e-02 | 1.370 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.373163e-02 | 1.359 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.990408e-02 | 1.399 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.756746e-02 | 1.323 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.756746e-02 | 1.323 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.736176e-02 | 1.325 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.126470e-02 | 1.384 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.756746e-02 | 1.323 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.163673e-02 | 1.381 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.953794e-02 | 1.305 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.736176e-02 | 1.325 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.903161e-02 | 1.310 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.115000e-02 | 1.386 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.996269e-02 | 1.398 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.126470e-02 | 1.384 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.058151e-02 | 1.392 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.343455e-02 | 1.362 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.270410e-02 | 1.370 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.717440e-02 | 1.326 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.834834e-02 | 1.316 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.982180e-02 | 1.400 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.954445e-02 | 1.305 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.987085e-02 | 1.302 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.063967e-02 | 1.296 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.161884e-02 | 1.287 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.161884e-02 | 1.287 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.170755e-02 | 1.286 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.170755e-02 | 1.286 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.170755e-02 | 1.286 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.172736e-02 | 1.286 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.292771e-02 | 1.276 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.301089e-02 | 1.276 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.301089e-02 | 1.276 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.301089e-02 | 1.276 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.420428e-02 | 1.266 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.492929e-02 | 1.260 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.542780e-02 | 1.256 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.621365e-02 | 1.250 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.621365e-02 | 1.250 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.624036e-02 | 1.250 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.930679e-02 | 1.227 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.930679e-02 | 1.227 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.930679e-02 | 1.227 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.970113e-02 | 1.224 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.020842e-02 | 1.220 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.036987e-02 | 1.219 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.073848e-02 | 1.217 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.349514e-02 | 1.197 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.388040e-02 | 1.195 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.388040e-02 | 1.195 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.388040e-02 | 1.195 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.482063e-02 | 1.188 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.488493e-02 | 1.188 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.574691e-02 | 1.182 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.577877e-02 | 1.182 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.636273e-02 | 1.178 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.636273e-02 | 1.178 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.640839e-02 | 1.178 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.668766e-02 | 1.176 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.668766e-02 | 1.176 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.674727e-02 | 1.176 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.677358e-02 | 1.175 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.762001e-02 | 1.170 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.772065e-02 | 1.169 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.777783e-02 | 1.169 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.777783e-02 | 1.169 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.777783e-02 | 1.169 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 8.946565e-02 | 1.048 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 8.946565e-02 | 1.048 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 8.946565e-02 | 1.048 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 8.946565e-02 | 1.048 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 8.946565e-02 | 1.048 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 8.946565e-02 | 1.048 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.938968e-02 | 1.100 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.938968e-02 | 1.100 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.704906e-02 | 1.060 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 8.704906e-02 | 1.060 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 8.704906e-02 | 1.060 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 8.704906e-02 | 1.060 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.704906e-02 | 1.060 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.627764e-02 | 1.064 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.627764e-02 | 1.064 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.236611e-02 | 1.084 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.726159e-02 | 1.112 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.179818e-02 | 1.144 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.179818e-02 | 1.144 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.756112e-02 | 1.110 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.096557e-02 | 1.149 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.096557e-02 | 1.149 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.173322e-02 | 1.088 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.173322e-02 | 1.088 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.060625e-02 | 1.094 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.934997e-02 | 1.049 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.107979e-02 | 1.091 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.784087e-02 | 1.109 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.715448e-02 | 1.113 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.099104e-02 | 1.092 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.438042e-02 | 1.129 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.312324e-02 | 1.136 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.099104e-02 | 1.092 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.984373e-02 | 1.047 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.312324e-02 | 1.136 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.897570e-02 | 1.051 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.953871e-02 | 1.099 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.596279e-02 | 1.119 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.471195e-02 | 1.072 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.327474e-02 | 1.135 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.471195e-02 | 1.072 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.236611e-02 | 1.084 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.834373e-02 | 1.054 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.984373e-02 | 1.047 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.859137e-02 | 1.105 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.946565e-02 | 1.048 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.865045e-02 | 1.104 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.507961e-02 | 1.070 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.627764e-02 | 1.064 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.950460e-02 | 1.048 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.974732e-02 | 1.047 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.915183e-02 | 1.050 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.915183e-02 | 1.050 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 7.938968e-02 | 1.100 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.236611e-02 | 1.084 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.413733e-02 | 1.130 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.085284e-02 | 1.042 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.869241e-02 | 1.052 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.837798e-02 | 1.165 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.215470e-02 | 1.035 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.588473e-02 | 1.018 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.648349e-02 | 1.016 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.665381e-02 | 1.015 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.819925e-02 | 1.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.819925e-02 | 1.008 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.876825e-02 | 1.005 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.983762e-02 | 1.001 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.983762e-02 | 1.001 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.983762e-02 | 1.001 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.983762e-02 | 1.001 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.013073e-01 | 0.994 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.032073e-01 | 0.986 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.032073e-01 | 0.986 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.032073e-01 | 0.986 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.035047e-01 | 0.985 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.040910e-01 | 0.983 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.043137e-01 | 0.982 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.043137e-01 | 0.982 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.046234e-01 | 0.980 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.071371e-01 | 0.970 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.076733e-01 | 0.968 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.077904e-01 | 0.967 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.077904e-01 | 0.967 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.077904e-01 | 0.967 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.077904e-01 | 0.967 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.077904e-01 | 0.967 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.077904e-01 | 0.967 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.085352e-01 | 0.964 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.085705e-01 | 0.964 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.088595e-01 | 0.963 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.093797e-01 | 0.961 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.097505e-01 | 0.960 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.097505e-01 | 0.960 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.113439e-01 | 0.953 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.121474e-01 | 0.950 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.121474e-01 | 0.950 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.121474e-01 | 0.950 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.126221e-01 | 0.948 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.126221e-01 | 0.948 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.126221e-01 | 0.948 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.129454e-01 | 0.947 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.131027e-01 | 0.947 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.136794e-01 | 0.944 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.141259e-01 | 0.943 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.160871e-01 | 0.935 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.177947e-01 | 0.929 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.197046e-01 | 0.922 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.197046e-01 | 0.922 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.207509e-01 | 0.918 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.215103e-01 | 0.915 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.237523e-01 | 0.907 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.263567e-01 | 0.898 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.263567e-01 | 0.898 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.271348e-01 | 0.896 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.283309e-01 | 0.892 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.302135e-01 | 0.885 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.302135e-01 | 0.885 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.302135e-01 | 0.885 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.302135e-01 | 0.885 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.302135e-01 | 0.885 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.302135e-01 | 0.885 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.306912e-01 | 0.884 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.306912e-01 | 0.884 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.306912e-01 | 0.884 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.306912e-01 | 0.884 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.352936e-01 | 0.869 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.391374e-01 | 0.857 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.400525e-01 | 0.854 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.400525e-01 | 0.854 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.400525e-01 | 0.854 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.400525e-01 | 0.854 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.400525e-01 | 0.854 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.528478e-01 | 0.816 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.528478e-01 | 0.816 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.528478e-01 | 0.816 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.528478e-01 | 0.816 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.528478e-01 | 0.816 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.528478e-01 | 0.816 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.528478e-01 | 0.816 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.528478e-01 | 0.816 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.432003e-01 | 0.844 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.432003e-01 | 0.844 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.432003e-01 | 0.844 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.432003e-01 | 0.844 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.017845e-01 | 0.695 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.017845e-01 | 0.695 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.491009e-01 | 0.827 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.491009e-01 | 0.827 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.491009e-01 | 0.827 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.491009e-01 | 0.827 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.410874e-01 | 0.851 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.893193e-01 | 0.723 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.893193e-01 | 0.723 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.893193e-01 | 0.723 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.720594e-01 | 0.764 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.553203e-01 | 0.809 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.553203e-01 | 0.809 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.051162e-01 | 0.688 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.051162e-01 | 0.688 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.822372e-01 | 0.739 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.625806e-01 | 0.789 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.455530e-01 | 0.837 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.455530e-01 | 0.837 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.107197e-01 | 0.676 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.107197e-01 | 0.676 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.660400e-01 | 0.780 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.495819e-01 | 0.825 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.672391e-01 | 0.777 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 1.877184e-01 | 0.726 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.877184e-01 | 0.726 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.670148e-01 | 0.777 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.870878e-01 | 0.728 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.104758e-01 | 0.677 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.658593e-01 | 0.780 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.658593e-01 | 0.780 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.853512e-01 | 0.732 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.078795e-01 | 0.682 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.509713e-01 | 0.821 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.798001e-01 | 0.745 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.984947e-01 | 0.702 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.486567e-01 | 0.828 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.705607e-01 | 0.768 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.771298e-01 | 0.752 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.943587e-01 | 0.711 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.053930e-01 | 0.687 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.943587e-01 | 0.711 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.486567e-01 | 0.828 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.720594e-01 | 0.764 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.865394e-01 | 0.729 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.672391e-01 | 0.777 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.865394e-01 | 0.729 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.865394e-01 | 0.729 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.672391e-01 | 0.777 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.036217e-01 | 0.691 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.800360e-01 | 0.745 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.078795e-01 | 0.682 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 1.720594e-01 | 0.764 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.792915e-01 | 0.746 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.593808e-01 | 0.798 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.891504e-01 | 0.723 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.660400e-01 | 0.780 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.660400e-01 | 0.780 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.045282e-01 | 0.689 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.788124e-01 | 0.748 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.800360e-01 | 0.745 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.512743e-01 | 0.820 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.107197e-01 | 0.676 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.107197e-01 | 0.676 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.640793e-01 | 0.785 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.715261e-01 | 0.766 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.966881e-01 | 0.706 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.410874e-01 | 0.851 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.506556e-01 | 0.822 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.882701e-01 | 0.725 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.670148e-01 | 0.777 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.893193e-01 | 0.723 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.107197e-01 | 0.676 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.829169e-01 | 0.738 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.893193e-01 | 0.723 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.829169e-01 | 0.738 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.893193e-01 | 0.723 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.660400e-01 | 0.780 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.822372e-01 | 0.739 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.104758e-01 | 0.677 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.107197e-01 | 0.676 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.865394e-01 | 0.729 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.660400e-01 | 0.780 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 1.625806e-01 | 0.789 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.017845e-01 | 0.695 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.812812e-01 | 0.742 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.043324e-01 | 0.690 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.720594e-01 | 0.764 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.017845e-01 | 0.695 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.104758e-01 | 0.677 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.840199e-01 | 0.735 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.491009e-01 | 0.827 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.112729e-01 | 0.675 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.115725e-01 | 0.675 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.117691e-01 | 0.674 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.117691e-01 | 0.674 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.117691e-01 | 0.674 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 2.823405e-01 | 0.549 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.823405e-01 | 0.549 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.823405e-01 | 0.549 | 0 | 0 |
| Defective MOGS causes CDG-2b | R-HSA-4793954 | 2.823405e-01 | 0.549 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.823405e-01 | 0.549 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.823405e-01 | 0.549 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.823405e-01 | 0.549 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.624817e-01 | 0.581 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.624817e-01 | 0.581 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.624817e-01 | 0.581 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.624817e-01 | 0.581 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.624817e-01 | 0.581 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.624817e-01 | 0.581 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.624817e-01 | 0.581 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.624817e-01 | 0.581 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.624817e-01 | 0.581 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.624817e-01 | 0.581 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.624817e-01 | 0.581 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.624817e-01 | 0.581 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.624817e-01 | 0.581 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.920457e-01 | 0.407 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.920457e-01 | 0.407 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.920457e-01 | 0.407 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.920457e-01 | 0.407 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.920457e-01 | 0.407 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 3.920457e-01 | 0.407 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.920457e-01 | 0.407 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.920457e-01 | 0.407 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.920457e-01 | 0.407 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.920457e-01 | 0.407 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.920457e-01 | 0.407 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.920457e-01 | 0.407 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.920457e-01 | 0.407 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.920457e-01 | 0.407 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.318878e-01 | 0.635 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.318878e-01 | 0.635 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.318878e-01 | 0.635 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.318878e-01 | 0.635 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.318878e-01 | 0.635 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.232782e-01 | 0.490 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.232782e-01 | 0.490 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.232782e-01 | 0.490 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.232782e-01 | 0.490 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.232782e-01 | 0.490 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.232782e-01 | 0.490 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.232782e-01 | 0.490 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.232782e-01 | 0.490 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.759500e-01 | 0.559 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.759500e-01 | 0.559 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.759500e-01 | 0.559 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.759500e-01 | 0.559 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 2.759500e-01 | 0.559 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.398207e-01 | 0.620 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.757374e-01 | 0.560 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.207341e-01 | 0.494 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.207341e-01 | 0.494 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.207341e-01 | 0.494 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.207341e-01 | 0.494 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.207341e-01 | 0.494 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.827260e-01 | 0.417 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.827260e-01 | 0.417 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.827260e-01 | 0.417 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.827260e-01 | 0.417 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.827260e-01 | 0.417 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.713353e-01 | 0.566 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.713353e-01 | 0.566 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.713353e-01 | 0.566 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.713353e-01 | 0.566 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.124462e-01 | 0.505 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.124462e-01 | 0.505 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.124462e-01 | 0.505 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.341900e-01 | 0.630 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.653436e-01 | 0.576 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.653436e-01 | 0.576 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.655653e-01 | 0.437 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.655653e-01 | 0.437 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.655653e-01 | 0.437 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.655653e-01 | 0.437 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.655653e-01 | 0.437 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.655653e-01 | 0.437 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.295233e-01 | 0.639 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.295233e-01 | 0.639 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.029354e-01 | 0.519 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.587310e-01 | 0.587 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.587310e-01 | 0.587 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.933236e-01 | 0.533 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.933236e-01 | 0.533 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.933236e-01 | 0.533 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.495524e-01 | 0.456 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.495524e-01 | 0.456 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.398173e-01 | 0.357 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.398173e-01 | 0.357 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.398173e-01 | 0.357 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.398173e-01 | 0.357 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.384287e-01 | 0.623 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.350478e-01 | 0.475 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.350478e-01 | 0.475 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.749730e-01 | 0.561 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.098703e-01 | 0.387 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.581812e-01 | 0.588 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.581812e-01 | 0.588 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.581812e-01 | 0.588 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.097522e-01 | 0.509 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.097522e-01 | 0.509 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.097522e-01 | 0.509 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.985709e-01 | 0.525 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.866937e-01 | 0.413 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.866937e-01 | 0.413 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.674235e-01 | 0.435 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.674235e-01 | 0.435 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.607055e-01 | 0.584 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.507502e-01 | 0.455 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.507502e-01 | 0.455 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.359580e-01 | 0.474 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.359580e-01 | 0.474 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.359580e-01 | 0.474 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.359580e-01 | 0.474 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.359580e-01 | 0.474 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.359580e-01 | 0.474 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.304805e-01 | 0.637 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.226086e-01 | 0.491 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.303574e-01 | 0.638 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.330110e-01 | 0.478 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.469785e-01 | 0.460 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.624458e-01 | 0.441 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.798403e-01 | 0.420 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.998287e-01 | 0.398 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.998287e-01 | 0.398 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.235448e-01 | 0.373 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.235448e-01 | 0.373 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 4.235448e-01 | 0.373 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.053257e-01 | 0.515 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.053257e-01 | 0.515 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.715743e-01 | 0.430 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.890838e-01 | 0.410 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.357697e-01 | 0.474 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.075058e-01 | 0.512 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.320474e-01 | 0.364 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.157453e-01 | 0.381 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.121211e-01 | 0.506 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.748650e-01 | 0.426 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.210319e-01 | 0.376 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.069121e-01 | 0.390 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.872805e-01 | 0.412 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.018422e-01 | 0.396 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.831212e-01 | 0.417 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.310846e-01 | 0.365 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.345498e-01 | 0.630 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.210319e-01 | 0.376 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.201048e-01 | 0.377 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.253664e-01 | 0.371 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.524589e-01 | 0.453 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.226086e-01 | 0.491 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.121211e-01 | 0.506 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.304805e-01 | 0.637 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.405079e-01 | 0.619 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.097522e-01 | 0.509 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.235448e-01 | 0.373 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.207341e-01 | 0.494 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.881723e-01 | 0.540 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.789502e-01 | 0.554 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.524589e-01 | 0.453 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.352692e-01 | 0.475 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.318878e-01 | 0.635 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.866937e-01 | 0.413 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.320474e-01 | 0.364 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.717424e-01 | 0.566 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.317543e-01 | 0.365 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.489488e-01 | 0.457 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.124462e-01 | 0.505 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.451203e-01 | 0.611 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.603226e-01 | 0.584 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.433784e-01 | 0.464 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.759500e-01 | 0.559 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.341900e-01 | 0.630 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.235448e-01 | 0.373 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.693165e-01 | 0.570 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.524825e-01 | 0.453 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.624458e-01 | 0.441 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.405079e-01 | 0.619 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.827260e-01 | 0.417 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.827260e-01 | 0.417 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.124462e-01 | 0.505 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.655653e-01 | 0.437 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.289314e-01 | 0.640 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.330110e-01 | 0.478 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.646241e-01 | 0.577 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.104116e-01 | 0.508 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.469785e-01 | 0.460 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.098703e-01 | 0.387 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.320474e-01 | 0.364 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.232782e-01 | 0.490 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.759500e-01 | 0.559 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.759500e-01 | 0.559 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.398173e-01 | 0.357 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.398173e-01 | 0.357 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.398173e-01 | 0.357 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.350478e-01 | 0.475 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.749730e-01 | 0.561 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 3.866937e-01 | 0.413 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.411473e-01 | 0.467 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.226086e-01 | 0.491 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.962923e-01 | 0.402 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.379417e-01 | 0.359 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.839641e-01 | 0.547 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.293080e-01 | 0.640 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.341900e-01 | 0.630 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.383833e-01 | 0.358 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.670581e-01 | 0.573 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.624458e-01 | 0.441 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.973631e-01 | 0.527 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.702457e-01 | 0.568 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.510327e-01 | 0.600 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.244764e-01 | 0.649 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.232782e-01 | 0.490 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.398207e-01 | 0.620 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.405079e-01 | 0.619 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.405079e-01 | 0.619 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.207341e-01 | 0.494 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.380973e-01 | 0.623 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.655653e-01 | 0.437 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.994828e-01 | 0.399 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.323801e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.778360e-01 | 0.556 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.219435e-01 | 0.654 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.713353e-01 | 0.566 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.207341e-01 | 0.494 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.379417e-01 | 0.359 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.341900e-01 | 0.630 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.552310e-01 | 0.449 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.821355e-01 | 0.550 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.524589e-01 | 0.453 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.671820e-01 | 0.435 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.827260e-01 | 0.417 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.218529e-01 | 0.492 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.985839e-01 | 0.399 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.671820e-01 | 0.435 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.991632e-01 | 0.524 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.081352e-01 | 0.389 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.783839e-01 | 0.422 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.265483e-01 | 0.486 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.081352e-01 | 0.389 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.984634e-01 | 0.400 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.232782e-01 | 0.490 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.469785e-01 | 0.460 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.784492e-01 | 0.555 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.521807e-01 | 0.598 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.182755e-01 | 0.497 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.503593e-01 | 0.601 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.075198e-01 | 0.390 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.823405e-01 | 0.549 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.624817e-01 | 0.581 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.624817e-01 | 0.581 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.624817e-01 | 0.581 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.920457e-01 | 0.407 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.920457e-01 | 0.407 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.232782e-01 | 0.490 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.232782e-01 | 0.490 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.232782e-01 | 0.490 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 3.232782e-01 | 0.490 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.232782e-01 | 0.490 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.350478e-01 | 0.475 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.350478e-01 | 0.475 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.866937e-01 | 0.413 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.214166e-01 | 0.655 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.089563e-01 | 0.388 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.798559e-01 | 0.553 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.224864e-01 | 0.491 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.688278e-01 | 0.571 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.521807e-01 | 0.598 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.359580e-01 | 0.474 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.159378e-01 | 0.381 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.466083e-01 | 0.608 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.921982e-01 | 0.534 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.207341e-01 | 0.494 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 3.866937e-01 | 0.413 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.384287e-01 | 0.623 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.098703e-01 | 0.387 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.008113e-01 | 0.397 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.144413e-01 | 0.383 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.759500e-01 | 0.559 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.089563e-01 | 0.388 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.287179e-01 | 0.483 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.581812e-01 | 0.588 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.398207e-01 | 0.620 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.827260e-01 | 0.417 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.285909e-01 | 0.483 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.350478e-01 | 0.475 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.402215e-01 | 0.468 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.587310e-01 | 0.587 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.398207e-01 | 0.620 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.757374e-01 | 0.560 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.653436e-01 | 0.576 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.210319e-01 | 0.376 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.827260e-01 | 0.417 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.226086e-01 | 0.491 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.210319e-01 | 0.376 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.124462e-01 | 0.505 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.827260e-01 | 0.417 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.089563e-01 | 0.388 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 3.827260e-01 | 0.417 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.029354e-01 | 0.519 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.232782e-01 | 0.490 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.207341e-01 | 0.494 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.827260e-01 | 0.417 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 3.655653e-01 | 0.437 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.734098e-01 | 0.428 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.827260e-01 | 0.417 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.827260e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.289822e-01 | 0.483 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.099329e-01 | 0.387 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.121187e-01 | 0.385 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.798403e-01 | 0.420 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.098703e-01 | 0.387 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.715743e-01 | 0.430 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.519219e-01 | 0.599 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.423101e-01 | 0.354 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.452486e-01 | 0.351 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.452486e-01 | 0.351 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.452486e-01 | 0.351 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.462522e-01 | 0.350 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.484105e-01 | 0.348 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.484105e-01 | 0.348 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.531752e-01 | 0.344 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.531752e-01 | 0.344 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.531752e-01 | 0.344 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.531752e-01 | 0.344 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.531752e-01 | 0.344 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.531752e-01 | 0.344 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.540802e-01 | 0.343 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.566389e-01 | 0.340 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.598199e-01 | 0.337 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.598199e-01 | 0.337 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.601628e-01 | 0.337 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.638837e-01 | 0.334 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.638837e-01 | 0.334 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.638837e-01 | 0.334 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.658164e-01 | 0.332 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.666517e-01 | 0.331 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.666517e-01 | 0.331 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.666517e-01 | 0.331 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.681272e-01 | 0.330 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.686656e-01 | 0.329 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.713999e-01 | 0.327 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.713999e-01 | 0.327 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.738149e-01 | 0.324 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.748339e-01 | 0.323 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.755751e-01 | 0.323 | 0 | 0 |
| Defective UGT1A4 causes hyperbilirubinemia | R-HSA-5579016 | 4.849860e-01 | 0.314 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.849860e-01 | 0.314 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.849860e-01 | 0.314 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 4.849860e-01 | 0.314 | 0 | 0 |
| Defective visual phototransduction due to STRA6 loss of function | R-HSA-9918449 | 4.849860e-01 | 0.314 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 4.849860e-01 | 0.314 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.849860e-01 | 0.314 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.849860e-01 | 0.314 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.849860e-01 | 0.314 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.849860e-01 | 0.314 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.849860e-01 | 0.314 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.929322e-01 | 0.307 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.934159e-01 | 0.307 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.936667e-01 | 0.307 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.936667e-01 | 0.307 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.938836e-01 | 0.306 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.938836e-01 | 0.306 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.938836e-01 | 0.306 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.938836e-01 | 0.306 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.938836e-01 | 0.306 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.938836e-01 | 0.306 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.938836e-01 | 0.306 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.938836e-01 | 0.306 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.938836e-01 | 0.306 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.941841e-01 | 0.306 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.941841e-01 | 0.306 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.949543e-01 | 0.305 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.949543e-01 | 0.305 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.951004e-01 | 0.305 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.951004e-01 | 0.305 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.951004e-01 | 0.305 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.951004e-01 | 0.305 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.951004e-01 | 0.305 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.951004e-01 | 0.305 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.951004e-01 | 0.305 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.951004e-01 | 0.305 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.951004e-01 | 0.305 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.951632e-01 | 0.305 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.951632e-01 | 0.305 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.951632e-01 | 0.305 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.952732e-01 | 0.305 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.952732e-01 | 0.305 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.952732e-01 | 0.305 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.952732e-01 | 0.305 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.955715e-01 | 0.305 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.066183e-01 | 0.295 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.153914e-01 | 0.288 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.166969e-01 | 0.287 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.167007e-01 | 0.287 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.183682e-01 | 0.285 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.183682e-01 | 0.285 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.183682e-01 | 0.285 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.183682e-01 | 0.285 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.183682e-01 | 0.285 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.203405e-01 | 0.284 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.203405e-01 | 0.284 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.227308e-01 | 0.282 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.227308e-01 | 0.282 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.227308e-01 | 0.282 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.246990e-01 | 0.280 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.257330e-01 | 0.279 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.257330e-01 | 0.279 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.257330e-01 | 0.279 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.296986e-01 | 0.276 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.296986e-01 | 0.276 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.296986e-01 | 0.276 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.296986e-01 | 0.276 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.353518e-01 | 0.271 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.353518e-01 | 0.271 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.353518e-01 | 0.271 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.353518e-01 | 0.271 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.362972e-01 | 0.271 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.362972e-01 | 0.271 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.376876e-01 | 0.269 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.388766e-01 | 0.269 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.418882e-01 | 0.266 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.418882e-01 | 0.266 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.442463e-01 | 0.264 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.445156e-01 | 0.264 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.445156e-01 | 0.264 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.445156e-01 | 0.264 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.445156e-01 | 0.264 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.445156e-01 | 0.264 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.445156e-01 | 0.264 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.445156e-01 | 0.264 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.461348e-01 | 0.263 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.485460e-01 | 0.261 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.485460e-01 | 0.261 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.492611e-01 | 0.260 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.493872e-01 | 0.260 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.493872e-01 | 0.260 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.498765e-01 | 0.260 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.498765e-01 | 0.260 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.509972e-01 | 0.259 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.509972e-01 | 0.259 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.538358e-01 | 0.257 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.554620e-01 | 0.255 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.606671e-01 | 0.251 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.629278e-01 | 0.250 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.629278e-01 | 0.250 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.629278e-01 | 0.250 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.629278e-01 | 0.250 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.629278e-01 | 0.250 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.636845e-01 | 0.249 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.637228e-01 | 0.249 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.637228e-01 | 0.249 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.637228e-01 | 0.249 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.637228e-01 | 0.249 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.637228e-01 | 0.249 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.637228e-01 | 0.249 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.637228e-01 | 0.249 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 5.637228e-01 | 0.249 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.637228e-01 | 0.249 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.637228e-01 | 0.249 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.637228e-01 | 0.249 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.637228e-01 | 0.249 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 5.637228e-01 | 0.249 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.649420e-01 | 0.248 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.649420e-01 | 0.248 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.675932e-01 | 0.246 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.698848e-01 | 0.244 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.700454e-01 | 0.244 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.737124e-01 | 0.241 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.737124e-01 | 0.241 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.737124e-01 | 0.241 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.737124e-01 | 0.241 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.737124e-01 | 0.241 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.737124e-01 | 0.241 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.739210e-01 | 0.241 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.763003e-01 | 0.239 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.790097e-01 | 0.237 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.808095e-01 | 0.236 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.820174e-01 | 0.235 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.820174e-01 | 0.235 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.842404e-01 | 0.233 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.842404e-01 | 0.233 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.842404e-01 | 0.233 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.874716e-01 | 0.231 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.914909e-01 | 0.228 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.914998e-01 | 0.228 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 5.914998e-01 | 0.228 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.914998e-01 | 0.228 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.914998e-01 | 0.228 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.914998e-01 | 0.228 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.914998e-01 | 0.228 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.914998e-01 | 0.228 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.914998e-01 | 0.228 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.914998e-01 | 0.228 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.923910e-01 | 0.227 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.939740e-01 | 0.226 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.948281e-01 | 0.226 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 5.948281e-01 | 0.226 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.012951e-01 | 0.221 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.027511e-01 | 0.220 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.028818e-01 | 0.220 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.028818e-01 | 0.220 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.028818e-01 | 0.220 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.061038e-01 | 0.217 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.080280e-01 | 0.216 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.100320e-01 | 0.215 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.100320e-01 | 0.215 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.100320e-01 | 0.215 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.100320e-01 | 0.215 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.100320e-01 | 0.215 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.110762e-01 | 0.214 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.110762e-01 | 0.214 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.110912e-01 | 0.214 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.110912e-01 | 0.214 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.119787e-01 | 0.213 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.119787e-01 | 0.213 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.167412e-01 | 0.210 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.172068e-01 | 0.210 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.203035e-01 | 0.207 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.251393e-01 | 0.204 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.252994e-01 | 0.204 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.252994e-01 | 0.204 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.287264e-01 | 0.202 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.293653e-01 | 0.201 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 6.304258e-01 | 0.200 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 6.304258e-01 | 0.200 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 6.304258e-01 | 0.200 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 6.304258e-01 | 0.200 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.304258e-01 | 0.200 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 6.304258e-01 | 0.200 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.304258e-01 | 0.200 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.347681e-01 | 0.197 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.347681e-01 | 0.197 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.347681e-01 | 0.197 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.347681e-01 | 0.197 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.347681e-01 | 0.197 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.347681e-01 | 0.197 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.347681e-01 | 0.197 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.347681e-01 | 0.197 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.347681e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.386066e-01 | 0.195 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.389628e-01 | 0.195 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.396957e-01 | 0.194 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.409788e-01 | 0.193 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.409788e-01 | 0.193 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.442181e-01 | 0.191 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.442181e-01 | 0.191 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.442181e-01 | 0.191 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.442181e-01 | 0.191 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.442181e-01 | 0.191 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.442181e-01 | 0.191 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.442181e-01 | 0.191 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.471872e-01 | 0.189 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.514378e-01 | 0.186 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.542714e-01 | 0.184 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.542714e-01 | 0.184 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.614012e-01 | 0.180 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.621848e-01 | 0.179 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.621848e-01 | 0.179 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.714275e-01 | 0.173 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 6.743584e-01 | 0.171 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.743584e-01 | 0.171 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.743584e-01 | 0.171 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.743584e-01 | 0.171 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.743584e-01 | 0.171 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.743584e-01 | 0.171 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.743584e-01 | 0.171 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.743584e-01 | 0.171 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.743584e-01 | 0.171 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.762265e-01 | 0.170 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.762265e-01 | 0.170 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.788763e-01 | 0.168 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.807567e-01 | 0.167 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.807567e-01 | 0.167 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.817000e-01 | 0.166 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.817000e-01 | 0.166 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.817000e-01 | 0.166 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.817000e-01 | 0.166 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.817000e-01 | 0.166 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.817000e-01 | 0.166 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.869337e-01 | 0.163 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.869337e-01 | 0.163 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.869337e-01 | 0.163 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.869337e-01 | 0.163 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.869337e-01 | 0.163 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.869337e-01 | 0.163 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.869337e-01 | 0.163 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.869337e-01 | 0.163 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.900724e-01 | 0.161 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.023459e-01 | 0.153 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.023459e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.055108e-01 | 0.151 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.060531e-01 | 0.151 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.060531e-01 | 0.151 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.060531e-01 | 0.151 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.060531e-01 | 0.151 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.075642e-01 | 0.150 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.075642e-01 | 0.150 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.092515e-01 | 0.149 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.103838e-01 | 0.149 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.103838e-01 | 0.149 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.103838e-01 | 0.149 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.103838e-01 | 0.149 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.103838e-01 | 0.149 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.103838e-01 | 0.149 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.159809e-01 | 0.145 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.162307e-01 | 0.145 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.199394e-01 | 0.143 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.225077e-01 | 0.141 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.270541e-01 | 0.138 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.270854e-01 | 0.138 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.318630e-01 | 0.136 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.331997e-01 | 0.135 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.331997e-01 | 0.135 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.337260e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.337260e-01 | 0.134 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.337260e-01 | 0.134 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.337260e-01 | 0.134 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.348044e-01 | 0.134 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 7.348044e-01 | 0.134 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.348044e-01 | 0.134 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.348044e-01 | 0.134 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.348044e-01 | 0.134 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.348044e-01 | 0.134 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 7.348044e-01 | 0.134 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.348044e-01 | 0.134 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 7.348044e-01 | 0.134 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 7.348044e-01 | 0.134 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 7.348044e-01 | 0.134 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.348044e-01 | 0.134 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.348044e-01 | 0.134 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.348044e-01 | 0.134 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.348044e-01 | 0.134 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.348044e-01 | 0.134 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.361217e-01 | 0.133 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.381257e-01 | 0.132 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.430088e-01 | 0.129 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.430088e-01 | 0.129 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.430088e-01 | 0.129 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.430088e-01 | 0.129 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.430088e-01 | 0.129 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.430088e-01 | 0.129 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.430088e-01 | 0.129 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.430088e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.430088e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.430088e-01 | 0.129 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.441051e-01 | 0.128 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.489687e-01 | 0.126 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.520242e-01 | 0.124 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.520242e-01 | 0.124 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.520242e-01 | 0.124 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.537911e-01 | 0.123 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.592992e-01 | 0.120 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.592992e-01 | 0.120 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.592992e-01 | 0.120 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.592992e-01 | 0.120 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.619551e-01 | 0.118 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.625436e-01 | 0.118 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.675576e-01 | 0.115 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.724307e-01 | 0.112 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.724307e-01 | 0.112 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.724307e-01 | 0.112 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.724307e-01 | 0.112 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.728695e-01 | 0.112 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.731705e-01 | 0.112 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.731705e-01 | 0.112 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.739712e-01 | 0.111 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.739712e-01 | 0.111 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.739712e-01 | 0.111 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.753574e-01 | 0.110 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.753574e-01 | 0.110 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.753574e-01 | 0.110 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 7.753574e-01 | 0.110 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.753574e-01 | 0.110 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.753574e-01 | 0.110 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 7.753574e-01 | 0.110 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 7.753574e-01 | 0.110 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.753574e-01 | 0.110 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.753574e-01 | 0.110 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.753574e-01 | 0.110 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.753574e-01 | 0.110 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.753574e-01 | 0.110 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.753574e-01 | 0.110 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.753574e-01 | 0.110 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.753574e-01 | 0.110 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.758420e-01 | 0.110 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.758420e-01 | 0.110 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.758420e-01 | 0.110 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.759445e-01 | 0.110 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.792611e-01 | 0.108 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.792611e-01 | 0.108 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.828461e-01 | 0.106 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.828461e-01 | 0.106 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.828461e-01 | 0.106 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.828461e-01 | 0.106 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.828461e-01 | 0.106 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.897297e-01 | 0.103 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.897297e-01 | 0.103 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.897454e-01 | 0.103 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.907398e-01 | 0.102 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.907398e-01 | 0.102 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.913599e-01 | 0.102 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.913599e-01 | 0.102 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.924303e-01 | 0.101 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.945581e-01 | 0.100 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.955935e-01 | 0.099 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.986220e-01 | 0.098 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.988663e-01 | 0.098 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.988663e-01 | 0.098 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.988663e-01 | 0.098 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.988663e-01 | 0.098 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.023522e-01 | 0.096 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.044549e-01 | 0.094 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.044549e-01 | 0.094 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.044549e-01 | 0.094 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.044549e-01 | 0.094 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.047961e-01 | 0.094 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.057260e-01 | 0.094 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.083885e-01 | 0.092 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.090586e-01 | 0.092 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 8.097112e-01 | 0.092 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.097112e-01 | 0.092 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.097112e-01 | 0.092 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 8.097112e-01 | 0.092 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 8.097112e-01 | 0.092 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.097112e-01 | 0.092 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 8.097112e-01 | 0.092 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 8.097112e-01 | 0.092 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.097112e-01 | 0.092 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 8.097112e-01 | 0.092 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 8.097112e-01 | 0.092 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 8.097112e-01 | 0.092 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 8.097112e-01 | 0.092 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 8.097112e-01 | 0.092 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 8.097112e-01 | 0.092 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.097112e-01 | 0.092 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.139176e-01 | 0.089 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.183724e-01 | 0.087 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.205921e-01 | 0.086 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.221601e-01 | 0.085 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.225406e-01 | 0.085 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.225406e-01 | 0.085 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.225406e-01 | 0.085 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.225406e-01 | 0.085 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.225406e-01 | 0.085 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.225406e-01 | 0.085 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.242238e-01 | 0.084 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.242238e-01 | 0.084 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.242913e-01 | 0.084 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.242913e-01 | 0.084 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.260671e-01 | 0.083 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.306860e-01 | 0.081 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.308716e-01 | 0.080 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.308716e-01 | 0.080 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.346131e-01 | 0.079 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.351920e-01 | 0.078 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.388130e-01 | 0.076 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.388130e-01 | 0.076 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.388130e-01 | 0.076 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.388130e-01 | 0.076 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.388130e-01 | 0.076 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 8.388130e-01 | 0.076 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.388130e-01 | 0.076 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.388130e-01 | 0.076 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.388130e-01 | 0.076 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.388130e-01 | 0.076 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.388130e-01 | 0.076 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.388130e-01 | 0.076 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.388130e-01 | 0.076 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 8.388130e-01 | 0.076 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.391081e-01 | 0.076 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.417660e-01 | 0.075 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.422578e-01 | 0.075 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.436798e-01 | 0.074 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.436798e-01 | 0.074 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.436798e-01 | 0.074 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.436798e-01 | 0.074 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.436798e-01 | 0.074 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.436798e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.445295e-01 | 0.073 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.465184e-01 | 0.072 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.476869e-01 | 0.072 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.477387e-01 | 0.072 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.562748e-01 | 0.067 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.565564e-01 | 0.067 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.565564e-01 | 0.067 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.586656e-01 | 0.066 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.600018e-01 | 0.066 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.600018e-01 | 0.066 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.609242e-01 | 0.065 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.612665e-01 | 0.065 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.615751e-01 | 0.065 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.625056e-01 | 0.064 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.625056e-01 | 0.064 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.625056e-01 | 0.064 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.625056e-01 | 0.064 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.625056e-01 | 0.064 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.634656e-01 | 0.064 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.634656e-01 | 0.064 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.634656e-01 | 0.064 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.634656e-01 | 0.064 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.634656e-01 | 0.064 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.634656e-01 | 0.064 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.634656e-01 | 0.064 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.634656e-01 | 0.064 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.634656e-01 | 0.064 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.634656e-01 | 0.064 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.656603e-01 | 0.063 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.672882e-01 | 0.062 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.672882e-01 | 0.062 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.735568e-01 | 0.059 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.735568e-01 | 0.059 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.792309e-01 | 0.056 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.792309e-01 | 0.056 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.792309e-01 | 0.056 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.825761e-01 | 0.054 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.838145e-01 | 0.054 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.843489e-01 | 0.053 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.843489e-01 | 0.053 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.843489e-01 | 0.053 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.843489e-01 | 0.053 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.843489e-01 | 0.053 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.843489e-01 | 0.053 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.843489e-01 | 0.053 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.843489e-01 | 0.053 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.843489e-01 | 0.053 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.870404e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.870404e-01 | 0.052 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.872327e-01 | 0.052 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.878247e-01 | 0.052 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.919727e-01 | 0.050 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.940577e-01 | 0.049 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.940577e-01 | 0.049 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.940577e-01 | 0.049 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.940577e-01 | 0.049 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.940577e-01 | 0.049 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.958177e-01 | 0.048 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.958222e-01 | 0.048 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.985012e-01 | 0.046 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.992231e-01 | 0.046 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.016350e-01 | 0.045 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 9.020390e-01 | 0.045 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 9.020390e-01 | 0.045 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 9.020390e-01 | 0.045 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 9.020390e-01 | 0.045 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 9.020390e-01 | 0.045 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.020390e-01 | 0.045 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 9.020390e-01 | 0.045 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 9.020390e-01 | 0.045 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 9.020390e-01 | 0.045 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 9.020390e-01 | 0.045 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 9.020390e-01 | 0.045 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.055246e-01 | 0.043 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.071755e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.071755e-01 | 0.042 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.071755e-01 | 0.042 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.071755e-01 | 0.042 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.071755e-01 | 0.042 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.075151e-01 | 0.042 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.075151e-01 | 0.042 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.075151e-01 | 0.042 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.077818e-01 | 0.042 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.102080e-01 | 0.041 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.102080e-01 | 0.041 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.102080e-01 | 0.041 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.167479e-01 | 0.038 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.167479e-01 | 0.038 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 9.170241e-01 | 0.038 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 9.170241e-01 | 0.038 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 9.170241e-01 | 0.038 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 9.170241e-01 | 0.038 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.187601e-01 | 0.037 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.200942e-01 | 0.036 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.247541e-01 | 0.034 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.247541e-01 | 0.034 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.251472e-01 | 0.034 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.263374e-01 | 0.033 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.263374e-01 | 0.033 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.283033e-01 | 0.032 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.284980e-01 | 0.032 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.289735e-01 | 0.032 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.289735e-01 | 0.032 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.289756e-01 | 0.032 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.291984e-01 | 0.032 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.297177e-01 | 0.032 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.297177e-01 | 0.032 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.297177e-01 | 0.032 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.297177e-01 | 0.032 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.327755e-01 | 0.030 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.327755e-01 | 0.030 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.327755e-01 | 0.030 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.331436e-01 | 0.030 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.369407e-01 | 0.028 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.378645e-01 | 0.028 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.378645e-01 | 0.028 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.396926e-01 | 0.027 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.396926e-01 | 0.027 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 9.404700e-01 | 0.027 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.404700e-01 | 0.027 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.404700e-01 | 0.027 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.404700e-01 | 0.027 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.404700e-01 | 0.027 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.404700e-01 | 0.027 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.404700e-01 | 0.027 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.404700e-01 | 0.027 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.404700e-01 | 0.027 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.404700e-01 | 0.027 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.404700e-01 | 0.027 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.404700e-01 | 0.027 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.404700e-01 | 0.027 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.430812e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.438542e-01 | 0.025 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.438542e-01 | 0.025 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.440727e-01 | 0.025 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.449972e-01 | 0.025 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 9.458668e-01 | 0.024 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.458668e-01 | 0.024 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.458668e-01 | 0.024 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.458668e-01 | 0.024 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.459552e-01 | 0.024 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.459552e-01 | 0.024 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.476088e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.495779e-01 | 0.022 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.495779e-01 | 0.022 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.495779e-01 | 0.022 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.495779e-01 | 0.022 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.495779e-01 | 0.022 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.495779e-01 | 0.022 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.495779e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.495779e-01 | 0.022 | 0 | 0 |
| Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) | R-HSA-9026766 | 9.495779e-01 | 0.022 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.495779e-01 | 0.022 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.495779e-01 | 0.022 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.504491e-01 | 0.022 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.516170e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.528040e-01 | 0.021 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.528040e-01 | 0.021 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.528040e-01 | 0.021 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.528040e-01 | 0.021 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.532135e-01 | 0.021 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.532135e-01 | 0.021 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.542933e-01 | 0.020 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.553459e-01 | 0.020 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.559957e-01 | 0.020 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.567284e-01 | 0.019 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.572927e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.572927e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.572927e-01 | 0.019 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.572927e-01 | 0.019 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.572927e-01 | 0.019 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.572927e-01 | 0.019 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.572927e-01 | 0.019 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.572927e-01 | 0.019 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.588863e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.588863e-01 | 0.018 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.588863e-01 | 0.018 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.590892e-01 | 0.018 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.612171e-01 | 0.017 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.612171e-01 | 0.017 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.612171e-01 | 0.017 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.613368e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.615651e-01 | 0.017 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.620047e-01 | 0.017 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.622664e-01 | 0.017 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.638275e-01 | 0.016 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.638275e-01 | 0.016 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.638275e-01 | 0.016 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.638275e-01 | 0.016 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.638275e-01 | 0.016 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.638275e-01 | 0.016 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.638275e-01 | 0.016 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.642126e-01 | 0.016 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.642126e-01 | 0.016 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.642126e-01 | 0.016 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.642126e-01 | 0.016 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.642126e-01 | 0.016 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.652924e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.654863e-01 | 0.015 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.657363e-01 | 0.015 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.657363e-01 | 0.015 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.657363e-01 | 0.015 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.657363e-01 | 0.015 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.660708e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.666635e-01 | 0.015 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.678863e-01 | 0.014 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.688719e-01 | 0.014 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.688719e-01 | 0.014 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.688719e-01 | 0.014 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.688719e-01 | 0.014 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.692180e-01 | 0.014 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.693627e-01 | 0.014 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.693627e-01 | 0.014 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.693627e-01 | 0.014 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.693627e-01 | 0.014 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.693627e-01 | 0.014 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.693627e-01 | 0.014 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.693627e-01 | 0.014 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.693627e-01 | 0.014 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.694388e-01 | 0.013 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.703881e-01 | 0.013 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.715673e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.725700e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.729156e-01 | 0.012 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.729437e-01 | 0.012 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.729437e-01 | 0.012 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.729437e-01 | 0.012 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.729437e-01 | 0.012 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.729437e-01 | 0.012 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.729869e-01 | 0.012 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.731063e-01 | 0.012 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.733250e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.735548e-01 | 0.012 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.740351e-01 | 0.011 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.740512e-01 | 0.011 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.740512e-01 | 0.011 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.740512e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.753327e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.753921e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.755774e-01 | 0.011 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.755774e-01 | 0.011 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.760775e-01 | 0.011 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.764985e-01 | 0.010 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.764985e-01 | 0.010 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.780224e-01 | 0.010 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.780224e-01 | 0.010 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.780224e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.780224e-01 | 0.010 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.782728e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.795992e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.795992e-01 | 0.009 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.797609e-01 | 0.009 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.800688e-01 | 0.009 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.813860e-01 | 0.008 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.813860e-01 | 0.008 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.813860e-01 | 0.008 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.813860e-01 | 0.008 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.813860e-01 | 0.008 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.813860e-01 | 0.008 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.817856e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.817856e-01 | 0.008 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.823015e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.826578e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.828109e-01 | 0.008 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.839843e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.840026e-01 | 0.007 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.842350e-01 | 0.007 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.842350e-01 | 0.007 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.842350e-01 | 0.007 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.842350e-01 | 0.007 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.859275e-01 | 0.006 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.859275e-01 | 0.006 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.861488e-01 | 0.006 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.866481e-01 | 0.006 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.866481e-01 | 0.006 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.866481e-01 | 0.006 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.866481e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.866481e-01 | 0.006 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.866481e-01 | 0.006 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.867023e-01 | 0.006 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.884828e-01 | 0.005 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.886920e-01 | 0.005 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 9.886920e-01 | 0.005 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 9.886920e-01 | 0.005 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.886920e-01 | 0.005 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.886920e-01 | 0.005 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.886920e-01 | 0.005 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.886920e-01 | 0.005 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.886920e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.888428e-01 | 0.005 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.896054e-01 | 0.005 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.896975e-01 | 0.004 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.900299e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.900299e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.900988e-01 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.900988e-01 | 0.004 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.904230e-01 | 0.004 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.904230e-01 | 0.004 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.904230e-01 | 0.004 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.904230e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.906149e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.913734e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.913734e-01 | 0.004 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.913734e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.916657e-01 | 0.004 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 9.918892e-01 | 0.004 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.918892e-01 | 0.004 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.918892e-01 | 0.004 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.921868e-01 | 0.003 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.926998e-01 | 0.003 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.931310e-01 | 0.003 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.931310e-01 | 0.003 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.931310e-01 | 0.003 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.935504e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.936092e-01 | 0.003 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.941827e-01 | 0.003 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.941827e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.941827e-01 | 0.003 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.941827e-01 | 0.003 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.941827e-01 | 0.003 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.941827e-01 | 0.003 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.941827e-01 | 0.003 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.941827e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.942454e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.942750e-01 | 0.002 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.944084e-01 | 0.002 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.944084e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.944269e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.944269e-01 | 0.002 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.950734e-01 | 0.002 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.950734e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.951863e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.951863e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.958278e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.958438e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.958438e-01 | 0.002 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.958438e-01 | 0.002 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.960725e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.962664e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.964129e-01 | 0.002 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.964667e-01 | 0.002 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.964667e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.965398e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.965846e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.966279e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.966793e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.970078e-01 | 0.001 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.970078e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.973172e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.973185e-01 | 0.001 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.973308e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.974661e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.978542e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.978889e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.978970e-01 | 0.001 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.981829e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.982911e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.982911e-01 | 0.001 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 9.984612e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.984612e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.984612e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.985280e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.985280e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.985458e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.985688e-01 | 0.001 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.986969e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.986969e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.988966e-01 | 0.000 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.988966e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.989089e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.989089e-01 | 0.000 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.989158e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.990569e-01 | 0.000 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.990656e-01 | 0.000 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.990656e-01 | 0.000 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.990656e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.990656e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.991681e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.991799e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.992208e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.992385e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.992906e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.993080e-01 | 0.000 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.993300e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.993300e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993357e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.994025e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994154e-01 | 0.000 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.994327e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.994412e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.994540e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.995040e-01 | 0.000 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.995196e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.995585e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.996206e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996481e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.996556e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.996740e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.997084e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.997084e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.997084e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997159e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.997531e-01 | 0.000 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.997531e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.997909e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998010e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.998479e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.998479e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.998501e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.998532e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998695e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998744e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998744e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998898e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.999090e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.999230e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.999230e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999274e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.999348e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.999395e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999481e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999531e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999555e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.999555e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.999581e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999635e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999716e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999720e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999761e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999761e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999768e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999788e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999789e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999803e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999805e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999824e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999854e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999854e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999854e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999863e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999877e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999877e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999894e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999919e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999937e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999941e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999947e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999962e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999963e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999964e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999967e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999973e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999975e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999976e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999977e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999988e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999997e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.110223e-16 | 15.955 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.881784e-16 | 15.051 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.221245e-15 | 14.913 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.330669e-15 | 14.477 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.551914e-15 | 14.342 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.551914e-15 | 14.342 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.882583e-15 | 14.103 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.993606e-15 | 14.097 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.438494e-15 | 14.129 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.660539e-15 | 14.116 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.110223e-14 | 13.955 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.953993e-14 | 13.709 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.997602e-14 | 13.523 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.084821e-14 | 13.294 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.395684e-14 | 13.268 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.128431e-14 | 13.213 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.250556e-14 | 13.204 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.160139e-14 | 13.088 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.024736e-13 | 12.989 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.232348e-13 | 12.909 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.233458e-13 | 12.909 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.249001e-13 | 12.903 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.303402e-13 | 12.885 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.858513e-13 | 12.731 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.490230e-13 | 12.604 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.483569e-13 | 12.605 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.611555e-13 | 12.442 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.859446e-13 | 12.313 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.859446e-13 | 12.313 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.266099e-13 | 12.203 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.443179e-12 | 11.841 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.565748e-12 | 11.805 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.574185e-12 | 11.803 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.680656e-12 | 11.775 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.122746e-12 | 11.673 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.395195e-12 | 11.621 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.566392e-12 | 11.591 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.002576e-12 | 11.398 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.199396e-12 | 11.284 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.243250e-12 | 11.280 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.599188e-12 | 11.252 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.171397e-12 | 11.210 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.693091e-12 | 11.174 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.775580e-12 | 11.169 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.185030e-12 | 11.144 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.149758e-11 | 10.939 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.358058e-11 | 10.867 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.379408e-11 | 10.860 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.689537e-11 | 10.772 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.402534e-11 | 10.619 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.532596e-11 | 10.596 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.056133e-11 | 10.515 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.692302e-11 | 10.329 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.695111e-11 | 10.328 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.168588e-11 | 10.210 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.339795e-11 | 10.198 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.554057e-11 | 10.122 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.063873e-10 | 9.973 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.475607e-10 | 9.831 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.763497e-10 | 9.754 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.890343e-10 | 9.723 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.021469e-10 | 9.694 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.685961e-10 | 9.571 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.685961e-10 | 9.571 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.879147e-10 | 9.541 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.745875e-10 | 9.426 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.365748e-10 | 9.360 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.380943e-10 | 9.358 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.251653e-10 | 9.140 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.820685e-10 | 9.054 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.070983e-09 | 8.970 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.184442e-09 | 8.926 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.452496e-09 | 8.838 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.780688e-09 | 8.749 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.725869e-09 | 8.763 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.799726e-09 | 8.745 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.546109e-09 | 8.594 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.546109e-09 | 8.594 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.901739e-09 | 8.537 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.797638e-09 | 8.420 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.002088e-08 | 7.999 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.338022e-08 | 7.874 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.378100e-08 | 7.861 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.473593e-08 | 7.832 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.599915e-08 | 7.796 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.800836e-08 | 7.745 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.821256e-08 | 7.740 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.975517e-08 | 7.704 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.094627e-08 | 7.679 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.147844e-08 | 7.668 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.596883e-08 | 7.586 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.922722e-08 | 7.534 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.846872e-08 | 7.415 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.085683e-08 | 7.389 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.493071e-08 | 7.347 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.517949e-08 | 7.345 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.530018e-08 | 7.344 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.992938e-08 | 7.302 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.830098e-08 | 7.166 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.088886e-08 | 7.149 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.143440e-08 | 7.039 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.089347e-07 | 6.963 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.308869e-07 | 6.883 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.395529e-07 | 6.855 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.508609e-07 | 6.821 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.821245e-07 | 6.740 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.812756e-07 | 6.742 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.819233e-07 | 6.740 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.951392e-07 | 6.710 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.311464e-07 | 6.636 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.324136e-07 | 6.634 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.609793e-07 | 6.583 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.710241e-07 | 6.567 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.158606e-07 | 6.501 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.564001e-07 | 6.448 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.760367e-07 | 6.425 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.163553e-07 | 6.381 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.177985e-07 | 6.286 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.486973e-07 | 6.261 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.963923e-07 | 6.224 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.179319e-07 | 6.144 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.081248e-07 | 6.093 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.988217e-07 | 6.046 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.988217e-07 | 6.046 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.988217e-07 | 6.046 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.916959e-07 | 6.050 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.988217e-07 | 6.046 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.757355e-07 | 6.058 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.794631e-07 | 6.009 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.859404e-07 | 6.006 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.053949e-06 | 5.977 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.059738e-06 | 5.975 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.536598e-06 | 5.813 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.536598e-06 | 5.813 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.437868e-06 | 5.842 | 0 | 0 |
| Translation | R-HSA-72766 | 1.418730e-06 | 5.848 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.429514e-06 | 5.845 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.606418e-06 | 5.794 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.656105e-06 | 5.781 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.745297e-06 | 5.758 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.850699e-06 | 5.733 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.124937e-06 | 5.673 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.355628e-06 | 5.628 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.410290e-06 | 5.618 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.586543e-06 | 5.587 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.789442e-06 | 5.554 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.031454e-06 | 5.518 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.044952e-06 | 5.516 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.183426e-06 | 5.497 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.188894e-06 | 5.496 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.302528e-06 | 5.481 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.406214e-06 | 5.468 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.653665e-06 | 5.437 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.764924e-06 | 5.424 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.913265e-06 | 5.407 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.141424e-06 | 5.289 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.983374e-06 | 5.223 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.347923e-06 | 5.197 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.346575e-06 | 5.197 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.586237e-06 | 5.181 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.586237e-06 | 5.181 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.033257e-06 | 5.153 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.087820e-06 | 5.149 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.163346e-06 | 5.145 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.034696e-06 | 5.095 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.760215e-06 | 5.057 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.243594e-06 | 5.034 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.365321e-06 | 5.028 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.365321e-06 | 5.028 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.317139e-05 | 4.880 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.334906e-05 | 4.875 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.347960e-05 | 4.870 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.347960e-05 | 4.870 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.515674e-05 | 4.819 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.636864e-05 | 4.786 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.577376e-05 | 4.802 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.617054e-05 | 4.791 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.556798e-05 | 4.808 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.644963e-05 | 4.784 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.796235e-05 | 4.746 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.901998e-05 | 4.721 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.942735e-05 | 4.712 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.966218e-05 | 4.706 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.011380e-05 | 4.697 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.035156e-05 | 4.691 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.150412e-05 | 4.667 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.205173e-05 | 4.657 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.416256e-05 | 4.617 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.471524e-05 | 4.607 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.471524e-05 | 4.607 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.599288e-05 | 4.585 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.132090e-05 | 4.504 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.876319e-05 | 4.541 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.150219e-05 | 4.502 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.996244e-05 | 4.523 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.128307e-05 | 4.505 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.242185e-05 | 4.489 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.386123e-05 | 4.470 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.573141e-05 | 4.447 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.632870e-05 | 4.440 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.699255e-05 | 4.432 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.699255e-05 | 4.432 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.823863e-05 | 4.417 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.953503e-05 | 4.403 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.258993e-05 | 4.371 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.335962e-05 | 4.363 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.472165e-05 | 4.349 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.561928e-05 | 4.341 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.065417e-05 | 4.295 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.763528e-05 | 4.239 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.799437e-05 | 4.237 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.088784e-05 | 4.215 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.088784e-05 | 4.215 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.241021e-05 | 4.205 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.539916e-05 | 4.184 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.373361e-05 | 4.132 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.187201e-05 | 4.087 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.207336e-05 | 4.086 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.765325e-05 | 4.057 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.008589e-05 | 4.096 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.364439e-05 | 4.078 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.719402e-05 | 4.012 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.719402e-05 | 4.012 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.728881e-05 | 4.012 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.979924e-05 | 4.001 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.074546e-04 | 3.969 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.113465e-04 | 3.953 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.113465e-04 | 3.953 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.184245e-04 | 3.927 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.211351e-04 | 3.917 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.297650e-04 | 3.887 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.319356e-04 | 3.880 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.321012e-04 | 3.879 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.358649e-04 | 3.867 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.358649e-04 | 3.867 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.482654e-04 | 3.829 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.697931e-04 | 3.770 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.697931e-04 | 3.770 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.888660e-04 | 3.724 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.985372e-04 | 3.702 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.989083e-04 | 3.701 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.010259e-04 | 3.697 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.189536e-04 | 3.660 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.316327e-04 | 3.635 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.402647e-04 | 3.619 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.402647e-04 | 3.619 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.481625e-04 | 3.605 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.545572e-04 | 3.594 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.085643e-04 | 3.511 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.085643e-04 | 3.511 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.927460e-04 | 3.534 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.986724e-04 | 3.525 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.085643e-04 | 3.511 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.833314e-04 | 3.548 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.103237e-04 | 3.508 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.114115e-04 | 3.507 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.178273e-04 | 3.498 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.495157e-04 | 3.457 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.521036e-04 | 3.453 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.783773e-04 | 3.422 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.858779e-04 | 3.414 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.903852e-04 | 3.409 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.907128e-04 | 3.408 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.937559e-04 | 3.405 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.013508e-04 | 3.396 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.045476e-04 | 3.393 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.072762e-04 | 3.390 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.467548e-04 | 3.350 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.473721e-04 | 3.349 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.574774e-04 | 3.340 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.658691e-04 | 3.332 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.658691e-04 | 3.332 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.766947e-04 | 3.322 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.815340e-04 | 3.317 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.839915e-04 | 3.315 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.883323e-04 | 3.311 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.883323e-04 | 3.311 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.963293e-04 | 3.304 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.129954e-04 | 3.290 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.190606e-04 | 3.285 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.284611e-04 | 3.277 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.361775e-04 | 3.271 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.462939e-04 | 3.263 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.848233e-04 | 3.164 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.106876e-04 | 3.214 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.764279e-04 | 3.239 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.006902e-04 | 3.221 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.060761e-04 | 3.217 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.970062e-04 | 3.224 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.196449e-04 | 3.208 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.196449e-04 | 3.208 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.370668e-04 | 3.196 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.887176e-04 | 3.162 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.060761e-04 | 3.217 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.060761e-04 | 3.217 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.060761e-04 | 3.217 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.614697e-04 | 3.179 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.755005e-04 | 3.240 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.172509e-04 | 3.210 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.327013e-04 | 3.135 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.471763e-04 | 3.127 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.510173e-04 | 3.124 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.852613e-04 | 3.105 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.861789e-04 | 3.104 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.956920e-04 | 3.099 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.215258e-04 | 3.085 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.581045e-04 | 3.066 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.630558e-04 | 3.064 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 9.252900e-04 | 3.034 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.319605e-04 | 3.031 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.341411e-04 | 3.030 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.592868e-04 | 3.018 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.795828e-04 | 3.009 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.014647e-03 | 2.994 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.014647e-03 | 2.994 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.016859e-03 | 2.993 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.016859e-03 | 2.993 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.018534e-03 | 2.992 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.031880e-03 | 2.986 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.058807e-03 | 2.975 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.058807e-03 | 2.975 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.075208e-03 | 2.969 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.111941e-03 | 2.954 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.114162e-03 | 2.953 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.114162e-03 | 2.953 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.120503e-03 | 2.951 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.148264e-03 | 2.940 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.157278e-03 | 2.937 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.157278e-03 | 2.937 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.173792e-03 | 2.930 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.191442e-03 | 2.924 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.197656e-03 | 2.922 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.348344e-03 | 2.870 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.352362e-03 | 2.869 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.388814e-03 | 2.857 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.388814e-03 | 2.857 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.393878e-03 | 2.856 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.393878e-03 | 2.856 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.393878e-03 | 2.856 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.393878e-03 | 2.856 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.396867e-03 | 2.855 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.405145e-03 | 2.852 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.405145e-03 | 2.852 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.428496e-03 | 2.845 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.435853e-03 | 2.843 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.581976e-03 | 2.801 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.630685e-03 | 2.788 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.787400e-03 | 2.748 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.787400e-03 | 2.748 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.767932e-03 | 2.753 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.748803e-03 | 2.757 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.941750e-03 | 2.712 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.767932e-03 | 2.753 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.977612e-03 | 2.704 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.708306e-03 | 2.767 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.779969e-03 | 2.750 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.051640e-03 | 2.688 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.072497e-03 | 2.684 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.138092e-03 | 2.670 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.138092e-03 | 2.670 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.151404e-03 | 2.667 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.267814e-03 | 2.644 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.267814e-03 | 2.644 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.267814e-03 | 2.644 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.274193e-03 | 2.643 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.311640e-03 | 2.636 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.329517e-03 | 2.633 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.377641e-03 | 2.624 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.478727e-03 | 2.606 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.511127e-03 | 2.600 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.539316e-03 | 2.595 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.623316e-03 | 2.581 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.727878e-03 | 2.564 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.727878e-03 | 2.564 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.738107e-03 | 2.563 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.803563e-03 | 2.552 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.862963e-03 | 2.543 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.913420e-03 | 2.536 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.941496e-03 | 2.531 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.959842e-03 | 2.529 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.093586e-03 | 2.510 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.093586e-03 | 2.510 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.253013e-03 | 2.488 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.266874e-03 | 2.486 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.281437e-03 | 2.484 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.288668e-03 | 2.483 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.324802e-03 | 2.478 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.330180e-03 | 2.478 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.330180e-03 | 2.478 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.431118e-03 | 2.465 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.577468e-03 | 2.446 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.786513e-03 | 2.422 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.786513e-03 | 2.422 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.790866e-03 | 2.421 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.790866e-03 | 2.421 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.891911e-03 | 2.410 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.938704e-03 | 2.405 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.985941e-03 | 2.399 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.985941e-03 | 2.399 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.035549e-03 | 2.394 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.035549e-03 | 2.394 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.152125e-03 | 2.382 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.152125e-03 | 2.382 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.218410e-03 | 2.375 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.218410e-03 | 2.375 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.219692e-03 | 2.375 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.300714e-03 | 2.366 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.593668e-03 | 2.338 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.612235e-03 | 2.336 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.612235e-03 | 2.336 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.644876e-03 | 2.333 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.822486e-03 | 2.317 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.822486e-03 | 2.317 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.822486e-03 | 2.317 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.856097e-03 | 2.314 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.856097e-03 | 2.314 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.879970e-03 | 2.312 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.879970e-03 | 2.312 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.033054e-03 | 2.219 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.106422e-03 | 2.292 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.352032e-03 | 2.271 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.708045e-03 | 2.173 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.708045e-03 | 2.173 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.643948e-03 | 2.178 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.954426e-03 | 2.225 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.347225e-03 | 2.272 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.185486e-03 | 2.209 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.347225e-03 | 2.272 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.352032e-03 | 2.271 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.030392e-03 | 2.220 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.663507e-03 | 2.176 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.663507e-03 | 2.176 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.347225e-03 | 2.272 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.297461e-03 | 2.201 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.297461e-03 | 2.201 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.225313e-03 | 2.282 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.804553e-03 | 2.236 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.352032e-03 | 2.271 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.352032e-03 | 2.271 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.416519e-03 | 2.266 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.707454e-03 | 2.244 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.625919e-03 | 2.179 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.347225e-03 | 2.272 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.894196e-03 | 2.162 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.894196e-03 | 2.162 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.894196e-03 | 2.162 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.075747e-03 | 2.150 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.350373e-03 | 2.134 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.367117e-03 | 2.133 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.377327e-03 | 2.132 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.699180e-03 | 2.114 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.887740e-03 | 2.103 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.961334e-03 | 2.099 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.979653e-03 | 2.098 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.979653e-03 | 2.098 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.209086e-03 | 2.086 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.598505e-03 | 2.066 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.698404e-03 | 2.061 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.722102e-03 | 2.059 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.866425e-03 | 2.052 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.898629e-03 | 2.051 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.055877e-03 | 2.043 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.055877e-03 | 2.043 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.372568e-03 | 2.028 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.696036e-03 | 2.013 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.930692e-03 | 2.003 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.972998e-03 | 2.001 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.972998e-03 | 2.001 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.972998e-03 | 2.001 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.019403e-02 | 1.992 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.020629e-02 | 1.991 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.025871e-02 | 1.989 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.029085e-02 | 1.988 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.035373e-02 | 1.985 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.035373e-02 | 1.985 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.035373e-02 | 1.985 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.036817e-02 | 1.984 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.053627e-02 | 1.977 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.112627e-02 | 1.954 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.150464e-02 | 1.939 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.151306e-02 | 1.939 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.151306e-02 | 1.939 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.158450e-02 | 1.936 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.158450e-02 | 1.936 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.167900e-02 | 1.933 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.167900e-02 | 1.933 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.170950e-02 | 1.931 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.170950e-02 | 1.931 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.239394e-02 | 1.907 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.239394e-02 | 1.907 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.253306e-02 | 1.902 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.253306e-02 | 1.902 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.275825e-02 | 1.894 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.275825e-02 | 1.894 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.294514e-02 | 1.888 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.294514e-02 | 1.888 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.320385e-02 | 1.879 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.323114e-02 | 1.878 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.329360e-02 | 1.876 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.346776e-02 | 1.871 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.366634e-02 | 1.864 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.366634e-02 | 1.864 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.366634e-02 | 1.864 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.383656e-02 | 1.859 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.414531e-02 | 1.849 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.457993e-02 | 1.836 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.457993e-02 | 1.836 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.457993e-02 | 1.836 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.457993e-02 | 1.836 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.473282e-02 | 1.832 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.489331e-02 | 1.827 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.489331e-02 | 1.827 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.489331e-02 | 1.827 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.495358e-02 | 1.825 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.495358e-02 | 1.825 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.519426e-02 | 1.818 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.547050e-02 | 1.810 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.547050e-02 | 1.810 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.547050e-02 | 1.810 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.547050e-02 | 1.810 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.557931e-02 | 1.807 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.594229e-02 | 1.797 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.594229e-02 | 1.797 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.611863e-02 | 1.793 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.625661e-02 | 1.789 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.637484e-02 | 1.786 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.637484e-02 | 1.786 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.637484e-02 | 1.786 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.652331e-02 | 1.782 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.684382e-02 | 1.774 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.725153e-02 | 1.763 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.361074e-02 | 1.627 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.184463e-02 | 1.661 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.184463e-02 | 1.661 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.263892e-02 | 1.645 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.506706e-02 | 1.601 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.930860e-02 | 1.714 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.468488e-02 | 1.608 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.888280e-02 | 1.724 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.888280e-02 | 1.724 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.197965e-02 | 1.658 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.542924e-02 | 1.595 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.542924e-02 | 1.595 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.166362e-02 | 1.664 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.765765e-02 | 1.753 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.165466e-02 | 1.664 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.506706e-02 | 1.601 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.506706e-02 | 1.601 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.310535e-02 | 1.636 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.095983e-02 | 1.679 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.012130e-02 | 1.696 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.930860e-02 | 1.714 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.783122e-02 | 1.749 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.966842e-02 | 1.706 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.500158e-02 | 1.602 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.493004e-02 | 1.603 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.102108e-02 | 1.677 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.468488e-02 | 1.608 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.883395e-02 | 1.725 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.346295e-02 | 1.630 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.981135e-02 | 1.703 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.980720e-02 | 1.703 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.974135e-02 | 1.705 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.888280e-02 | 1.724 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.034611e-02 | 1.692 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.539603e-02 | 1.595 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.613083e-02 | 1.583 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.755389e-02 | 1.756 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.095983e-02 | 1.679 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.888280e-02 | 1.724 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.966842e-02 | 1.706 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.165466e-02 | 1.664 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.520228e-02 | 1.599 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.166362e-02 | 1.664 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.541041e-02 | 1.595 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.974135e-02 | 1.705 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.878788e-02 | 1.726 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.634318e-02 | 1.579 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.634318e-02 | 1.579 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.634318e-02 | 1.579 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.750590e-02 | 1.561 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.750590e-02 | 1.561 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.762550e-02 | 1.559 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.830843e-02 | 1.548 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.878048e-02 | 1.541 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.878048e-02 | 1.541 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.889433e-02 | 1.539 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.916649e-02 | 1.535 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.916649e-02 | 1.535 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.026251e-02 | 1.519 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.026251e-02 | 1.519 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.041331e-02 | 1.517 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.099613e-02 | 1.509 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.128892e-02 | 1.505 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.153656e-02 | 1.501 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.153656e-02 | 1.501 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.166819e-02 | 1.499 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.239485e-02 | 1.490 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.239485e-02 | 1.490 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.257223e-02 | 1.487 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.257223e-02 | 1.487 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.332980e-02 | 1.477 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.332980e-02 | 1.477 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.346207e-02 | 1.475 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.361462e-02 | 1.473 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.361462e-02 | 1.473 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.361462e-02 | 1.473 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.463394e-02 | 1.460 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.467268e-02 | 1.460 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.467268e-02 | 1.460 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.467268e-02 | 1.460 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.467268e-02 | 1.460 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.467268e-02 | 1.460 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.467268e-02 | 1.460 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.548410e-02 | 1.450 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.613671e-02 | 1.442 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.618947e-02 | 1.441 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.624721e-02 | 1.441 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.729865e-02 | 1.428 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.784474e-02 | 1.422 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.796310e-02 | 1.421 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.835280e-02 | 1.416 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.968566e-02 | 1.401 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.008457e-02 | 1.397 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.221869e-02 | 1.374 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.221869e-02 | 1.374 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.221869e-02 | 1.374 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 4.221869e-02 | 1.374 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.230444e-02 | 1.374 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.230444e-02 | 1.374 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.230444e-02 | 1.374 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.271732e-02 | 1.369 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.271732e-02 | 1.369 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.271732e-02 | 1.369 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.291054e-02 | 1.367 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.311968e-02 | 1.365 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.386734e-02 | 1.358 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.386734e-02 | 1.358 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.387721e-02 | 1.358 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.387721e-02 | 1.358 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.387721e-02 | 1.358 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.636115e-02 | 1.334 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.689600e-02 | 1.329 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.854454e-02 | 1.314 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.922328e-02 | 1.308 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.922328e-02 | 1.308 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.002652e-02 | 1.301 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.002652e-02 | 1.301 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.051038e-02 | 1.297 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.051038e-02 | 1.297 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.060288e-02 | 1.296 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.060288e-02 | 1.296 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.216095e-02 | 1.283 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.222793e-02 | 1.282 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.222793e-02 | 1.282 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.222793e-02 | 1.282 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.222793e-02 | 1.282 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.227340e-02 | 1.282 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.227340e-02 | 1.282 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.227340e-02 | 1.282 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.338672e-02 | 1.273 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.391829e-02 | 1.268 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.451674e-02 | 1.263 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.451674e-02 | 1.263 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.469821e-02 | 1.262 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.469821e-02 | 1.262 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.469821e-02 | 1.262 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.469821e-02 | 1.262 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.469821e-02 | 1.262 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.510797e-02 | 1.259 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.510797e-02 | 1.259 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.577116e-02 | 1.254 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.643037e-02 | 1.248 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.643037e-02 | 1.248 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.667392e-02 | 1.247 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.667392e-02 | 1.247 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.667392e-02 | 1.247 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.667392e-02 | 1.247 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.680992e-02 | 1.246 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.775870e-02 | 1.238 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.775870e-02 | 1.238 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.775870e-02 | 1.238 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.804956e-02 | 1.236 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.808080e-02 | 1.236 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.808080e-02 | 1.236 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.808080e-02 | 1.236 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.808080e-02 | 1.236 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.080402e-02 | 1.216 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.083519e-02 | 1.216 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.155029e-02 | 1.211 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.155029e-02 | 1.211 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.155029e-02 | 1.211 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.339481e-02 | 1.198 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.339481e-02 | 1.198 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.339481e-02 | 1.198 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.350210e-02 | 1.197 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.657888e-02 | 1.177 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.677906e-02 | 1.175 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.689072e-02 | 1.175 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.791577e-02 | 1.168 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.844777e-02 | 1.165 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.894992e-02 | 1.161 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.894992e-02 | 1.161 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.894992e-02 | 1.161 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.894992e-02 | 1.161 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.894992e-02 | 1.161 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.894992e-02 | 1.161 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.894992e-02 | 1.161 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.946267e-02 | 1.158 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.946267e-02 | 1.158 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.946267e-02 | 1.158 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.946267e-02 | 1.158 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.974085e-02 | 1.157 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.082820e-02 | 1.150 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.084272e-02 | 1.150 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.111156e-02 | 1.148 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.111156e-02 | 1.148 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.111156e-02 | 1.148 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.215806e-02 | 1.142 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.215806e-02 | 1.142 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.215806e-02 | 1.142 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.505391e-02 | 1.125 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.579770e-02 | 1.120 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.579770e-02 | 1.120 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.579770e-02 | 1.120 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.579770e-02 | 1.120 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.579770e-02 | 1.120 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.579770e-02 | 1.120 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.742849e-02 | 1.111 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.784175e-02 | 1.109 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.784175e-02 | 1.109 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.954216e-02 | 1.099 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.954216e-02 | 1.099 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.974973e-02 | 1.098 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.974973e-02 | 1.098 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 8.114688e-02 | 1.091 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 8.114688e-02 | 1.091 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 8.114688e-02 | 1.091 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.114688e-02 | 1.091 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.114688e-02 | 1.091 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 8.114688e-02 | 1.091 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 8.114688e-02 | 1.091 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 8.114688e-02 | 1.091 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.284250e-02 | 1.082 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.328010e-02 | 1.079 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.328010e-02 | 1.079 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.344671e-02 | 1.079 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.108019e-01 | 0.955 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.108019e-01 | 0.955 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.108019e-01 | 0.955 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.108019e-01 | 0.955 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.108019e-01 | 0.955 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.108019e-01 | 0.955 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.108019e-01 | 0.955 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.108019e-01 | 0.955 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.108019e-01 | 0.955 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.108019e-01 | 0.955 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.108019e-01 | 0.955 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.108019e-01 | 0.955 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.108019e-01 | 0.955 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.176700e-01 | 0.929 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.176700e-01 | 0.929 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.176700e-01 | 0.929 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.573826e-01 | 0.803 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.573826e-01 | 0.803 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.573826e-01 | 0.803 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.573826e-01 | 0.803 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.149365e-01 | 0.940 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.149365e-01 | 0.940 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.149365e-01 | 0.940 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.409356e-01 | 0.851 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.409356e-01 | 0.851 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.409356e-01 | 0.851 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.409356e-01 | 0.851 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.409356e-01 | 0.851 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.941317e-02 | 1.049 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.941317e-02 | 1.049 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.216189e-01 | 0.915 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.216189e-01 | 0.915 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.686712e-01 | 0.773 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.686712e-01 | 0.773 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.686712e-01 | 0.773 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.686712e-01 | 0.773 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.686712e-01 | 0.773 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.686712e-01 | 0.773 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.042032e-01 | 0.982 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.042032e-01 | 0.982 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.042032e-01 | 0.982 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.921418e-02 | 1.050 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.201168e-01 | 0.920 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.201168e-01 | 0.920 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.201168e-01 | 0.920 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.370916e-01 | 0.863 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.787123e-02 | 1.009 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.787123e-02 | 1.009 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.222331e-01 | 0.913 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.144781e-01 | 0.941 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.354728e-01 | 0.868 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.069765e-01 | 0.971 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.094817e-01 | 0.961 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.267976e-01 | 0.897 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.814542e-02 | 1.008 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.481385e-01 | 0.829 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.921418e-02 | 1.050 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.795943e-02 | 1.056 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.984605e-02 | 1.001 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.299732e-01 | 0.886 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.452501e-01 | 0.838 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.354728e-01 | 0.868 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.848539e-02 | 1.053 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.613007e-01 | 0.792 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.613007e-01 | 0.792 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.941317e-02 | 1.049 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.787123e-02 | 1.009 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.216189e-01 | 0.915 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.550556e-01 | 0.810 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.573826e-01 | 0.803 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.409356e-01 | 0.851 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.216189e-01 | 0.915 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.921418e-02 | 1.050 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.638728e-01 | 0.785 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.370916e-01 | 0.863 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.611468e-01 | 0.793 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.686712e-01 | 0.773 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.613007e-01 | 0.792 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.252673e-01 | 0.902 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.611468e-01 | 0.793 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.144781e-01 | 0.941 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.149365e-01 | 0.940 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.921418e-02 | 1.050 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.427286e-01 | 0.845 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.305459e-02 | 1.031 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.357202e-01 | 0.867 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.491539e-02 | 1.071 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.409356e-01 | 0.851 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.638728e-01 | 0.785 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.190195e-01 | 0.924 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.270639e-01 | 0.896 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.042032e-01 | 0.982 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.550556e-01 | 0.810 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.814542e-02 | 1.008 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.984605e-02 | 1.001 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.176700e-01 | 0.929 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.573826e-01 | 0.803 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.216189e-01 | 0.915 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.096915e-01 | 0.960 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.144781e-01 | 0.941 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.386790e-01 | 0.858 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.597219e-01 | 0.797 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.679013e-02 | 1.062 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.775651e-02 | 1.057 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.020582e-01 | 0.991 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.914879e-02 | 1.004 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.110679e-02 | 1.040 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.457973e-02 | 1.073 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.686712e-01 | 0.773 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.149365e-01 | 0.940 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.409356e-01 | 0.851 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.067947e-01 | 0.971 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.494953e-02 | 1.023 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.216189e-01 | 0.915 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.216189e-01 | 0.915 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.299732e-01 | 0.886 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.550556e-01 | 0.810 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.019186e-01 | 0.992 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.638728e-01 | 0.785 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.719846e-02 | 1.012 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.941317e-02 | 1.049 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.921418e-02 | 1.050 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.025081e-01 | 0.989 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.216189e-01 | 0.915 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.216189e-01 | 0.915 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.921418e-02 | 1.050 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.305459e-02 | 1.031 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.093781e-01 | 0.961 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.815606e-02 | 1.055 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.222331e-01 | 0.913 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.738131e-01 | 0.760 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.739292e-01 | 0.760 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.739292e-01 | 0.760 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.739292e-01 | 0.760 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.739292e-01 | 0.760 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.739292e-01 | 0.760 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.780734e-01 | 0.749 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.782369e-01 | 0.749 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.782888e-01 | 0.749 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.797799e-01 | 0.745 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.822401e-01 | 0.739 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.822401e-01 | 0.739 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.822401e-01 | 0.739 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.822401e-01 | 0.739 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.822401e-01 | 0.739 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.824737e-01 | 0.739 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.845511e-01 | 0.734 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.848138e-01 | 0.733 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.848138e-01 | 0.733 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.860747e-01 | 0.730 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.867266e-01 | 0.729 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.867266e-01 | 0.729 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.892882e-01 | 0.723 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.896085e-01 | 0.722 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.896085e-01 | 0.722 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.896085e-01 | 0.722 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.926325e-01 | 0.715 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.926325e-01 | 0.715 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.936264e-01 | 0.713 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.936264e-01 | 0.713 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.948015e-01 | 0.710 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.955127e-01 | 0.709 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.955127e-01 | 0.709 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.955127e-01 | 0.709 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.978134e-01 | 0.704 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.978134e-01 | 0.704 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.978134e-01 | 0.704 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.978134e-01 | 0.704 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.991304e-01 | 0.701 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.991304e-01 | 0.701 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.991304e-01 | 0.701 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.991304e-01 | 0.701 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.991304e-01 | 0.701 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.991304e-01 | 0.701 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.991304e-01 | 0.701 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.991304e-01 | 0.701 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 1.991304e-01 | 0.701 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.991304e-01 | 0.701 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.991304e-01 | 0.701 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.991304e-01 | 0.701 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.991304e-01 | 0.701 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.991304e-01 | 0.701 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.021087e-01 | 0.694 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.074377e-01 | 0.683 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.093324e-01 | 0.679 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.093324e-01 | 0.679 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.093324e-01 | 0.679 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.093324e-01 | 0.679 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.093324e-01 | 0.679 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.093324e-01 | 0.679 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.093324e-01 | 0.679 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.093324e-01 | 0.679 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.093324e-01 | 0.679 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.093324e-01 | 0.679 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.093324e-01 | 0.679 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.093324e-01 | 0.679 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.105278e-01 | 0.677 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.110410e-01 | 0.676 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 2.135591e-01 | 0.670 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.135591e-01 | 0.670 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.142643e-01 | 0.669 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.174367e-01 | 0.663 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.174367e-01 | 0.663 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.249208e-01 | 0.648 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.280426e-01 | 0.642 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.285135e-01 | 0.641 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.285135e-01 | 0.641 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.313186e-01 | 0.636 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.321508e-01 | 0.634 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.321508e-01 | 0.634 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.351205e-01 | 0.629 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.351205e-01 | 0.629 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.351205e-01 | 0.629 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.351205e-01 | 0.629 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.351278e-01 | 0.629 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.406457e-01 | 0.619 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.419754e-01 | 0.616 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.419754e-01 | 0.616 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.419754e-01 | 0.616 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.419754e-01 | 0.616 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.419754e-01 | 0.616 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.419754e-01 | 0.616 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.431868e-01 | 0.614 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.438337e-01 | 0.613 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.441306e-01 | 0.612 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.449103e-01 | 0.611 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.449103e-01 | 0.611 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.512236e-01 | 0.600 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.583551e-01 | 0.588 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.590560e-01 | 0.587 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.590560e-01 | 0.587 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.590560e-01 | 0.587 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.590560e-01 | 0.587 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.590560e-01 | 0.587 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.590560e-01 | 0.587 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.590560e-01 | 0.587 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.603498e-01 | 0.584 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.603498e-01 | 0.584 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.603498e-01 | 0.584 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.615669e-01 | 0.582 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.707125e-01 | 0.567 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.753076e-01 | 0.560 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.766773e-01 | 0.558 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.771175e-01 | 0.557 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.803208e-01 | 0.552 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.851624e-01 | 0.545 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.851624e-01 | 0.545 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.851624e-01 | 0.545 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.851624e-01 | 0.545 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.851624e-01 | 0.545 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.851624e-01 | 0.545 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.851624e-01 | 0.545 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.851624e-01 | 0.545 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.851624e-01 | 0.545 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.860646e-01 | 0.544 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.860646e-01 | 0.544 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.860646e-01 | 0.544 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.905518e-01 | 0.537 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.905716e-01 | 0.537 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.905716e-01 | 0.537 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.905716e-01 | 0.537 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.905716e-01 | 0.537 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.905716e-01 | 0.537 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.905716e-01 | 0.537 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.905716e-01 | 0.537 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.905716e-01 | 0.537 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.905716e-01 | 0.537 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.905716e-01 | 0.537 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.905716e-01 | 0.537 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.969501e-01 | 0.527 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.969501e-01 | 0.527 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.969501e-01 | 0.527 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.969501e-01 | 0.527 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.969501e-01 | 0.527 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.969501e-01 | 0.527 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.969501e-01 | 0.527 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.969501e-01 | 0.527 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.969501e-01 | 0.527 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.969501e-01 | 0.527 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.969501e-01 | 0.527 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.969501e-01 | 0.527 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.969501e-01 | 0.527 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.969501e-01 | 0.527 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.969501e-01 | 0.527 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.984833e-01 | 0.525 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.984833e-01 | 0.525 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.984833e-01 | 0.525 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.012327e-01 | 0.521 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.012327e-01 | 0.521 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.042840e-01 | 0.517 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.042840e-01 | 0.517 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.042840e-01 | 0.517 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.106759e-01 | 0.508 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.106759e-01 | 0.508 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.121190e-01 | 0.506 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.121190e-01 | 0.506 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.121190e-01 | 0.506 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.121190e-01 | 0.506 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.168854e-01 | 0.499 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.168854e-01 | 0.499 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.210824e-01 | 0.493 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.223313e-01 | 0.492 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.223313e-01 | 0.492 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.223313e-01 | 0.492 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.223313e-01 | 0.492 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.223313e-01 | 0.492 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.223313e-01 | 0.492 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.223313e-01 | 0.492 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.231572e-01 | 0.491 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.239192e-01 | 0.490 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.239192e-01 | 0.490 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.280899e-01 | 0.484 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.280899e-01 | 0.484 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.280899e-01 | 0.484 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.280899e-01 | 0.484 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.280899e-01 | 0.484 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.280899e-01 | 0.484 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.280899e-01 | 0.484 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.280899e-01 | 0.484 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.280899e-01 | 0.484 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.280899e-01 | 0.484 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.280899e-01 | 0.484 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.280899e-01 | 0.484 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.280899e-01 | 0.484 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.383741e-01 | 0.471 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.383741e-01 | 0.471 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.383741e-01 | 0.471 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.467802e-01 | 0.460 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.467802e-01 | 0.460 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.541020e-01 | 0.451 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.541020e-01 | 0.451 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.541020e-01 | 0.451 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.542148e-01 | 0.451 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.553687e-01 | 0.449 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.559959e-01 | 0.449 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.562750e-01 | 0.448 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.646993e-01 | 0.438 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.697299e-01 | 0.432 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.702855e-01 | 0.431 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.702855e-01 | 0.431 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.702855e-01 | 0.431 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.702855e-01 | 0.431 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.702855e-01 | 0.431 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.728712e-01 | 0.428 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.748630e-01 | 0.426 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.748630e-01 | 0.426 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.748630e-01 | 0.426 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.748630e-01 | 0.426 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.748630e-01 | 0.426 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.748630e-01 | 0.426 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 3.748630e-01 | 0.426 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.748630e-01 | 0.426 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.748630e-01 | 0.426 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.748630e-01 | 0.426 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.748630e-01 | 0.426 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.830428e-01 | 0.417 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.856762e-01 | 0.414 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.856762e-01 | 0.414 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.856762e-01 | 0.414 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.856762e-01 | 0.414 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.889832e-01 | 0.410 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.889832e-01 | 0.410 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.909730e-01 | 0.408 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.926863e-01 | 0.406 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.926863e-01 | 0.406 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.927456e-01 | 0.406 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.927456e-01 | 0.406 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.927456e-01 | 0.406 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.927456e-01 | 0.406 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.986394e-01 | 0.399 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.026606e-01 | 0.395 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.054024e-01 | 0.392 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 4.113843e-01 | 0.386 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.113843e-01 | 0.386 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.113843e-01 | 0.386 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.113843e-01 | 0.386 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.113843e-01 | 0.386 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.113843e-01 | 0.386 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.113843e-01 | 0.386 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.155722e-01 | 0.381 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.168716e-01 | 0.380 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.168716e-01 | 0.380 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.168716e-01 | 0.380 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.168716e-01 | 0.380 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.170832e-01 | 0.380 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.170832e-01 | 0.380 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.170832e-01 | 0.380 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.170832e-01 | 0.380 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.170832e-01 | 0.380 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.296660e-01 | 0.367 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.429279e-01 | 0.354 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.429279e-01 | 0.354 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.429279e-01 | 0.354 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.429279e-01 | 0.354 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.437559e-01 | 0.353 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.441456e-01 | 0.352 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.441456e-01 | 0.352 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.441456e-01 | 0.352 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.441456e-01 | 0.352 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.441456e-01 | 0.352 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.441456e-01 | 0.352 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.441456e-01 | 0.352 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.441456e-01 | 0.352 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.475308e-01 | 0.349 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.475308e-01 | 0.349 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.475308e-01 | 0.349 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.475308e-01 | 0.349 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.475308e-01 | 0.349 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.484375e-01 | 0.348 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.511115e-01 | 0.346 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.511115e-01 | 0.346 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.511115e-01 | 0.346 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.511115e-01 | 0.346 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.511115e-01 | 0.346 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.511115e-01 | 0.346 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.511115e-01 | 0.346 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.511115e-01 | 0.346 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.511115e-01 | 0.346 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.542870e-01 | 0.343 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.542870e-01 | 0.343 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.542870e-01 | 0.343 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.608488e-01 | 0.336 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.684154e-01 | 0.329 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.684154e-01 | 0.329 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.745132e-01 | 0.324 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.745132e-01 | 0.324 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.775193e-01 | 0.321 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.775193e-01 | 0.321 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.775193e-01 | 0.321 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.775193e-01 | 0.321 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.831108e-01 | 0.316 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.855916e-01 | 0.314 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.890864e-01 | 0.311 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.892663e-01 | 0.310 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.892663e-01 | 0.310 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.892663e-01 | 0.310 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.892663e-01 | 0.310 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.892663e-01 | 0.310 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.892663e-01 | 0.310 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.892663e-01 | 0.310 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.892663e-01 | 0.310 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.892663e-01 | 0.310 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.892663e-01 | 0.310 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.934637e-01 | 0.307 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.934637e-01 | 0.307 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.039028e-01 | 0.298 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.050451e-01 | 0.297 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.050451e-01 | 0.297 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.057533e-01 | 0.296 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.057533e-01 | 0.296 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.057533e-01 | 0.296 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 5.057533e-01 | 0.296 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.057533e-01 | 0.296 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.057533e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.057533e-01 | 0.296 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.057533e-01 | 0.296 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.057533e-01 | 0.296 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.057533e-01 | 0.296 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.067248e-01 | 0.295 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.067248e-01 | 0.295 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.067248e-01 | 0.295 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.142597e-01 | 0.289 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.180010e-01 | 0.286 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.189622e-01 | 0.285 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 5.219930e-01 | 0.282 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.257094e-01 | 0.279 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.257094e-01 | 0.279 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.257094e-01 | 0.279 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.257094e-01 | 0.279 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.266011e-01 | 0.279 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.266011e-01 | 0.279 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.337005e-01 | 0.273 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.350553e-01 | 0.272 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.350553e-01 | 0.272 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.350553e-01 | 0.272 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.350553e-01 | 0.272 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.374159e-01 | 0.270 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.398323e-01 | 0.268 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.419650e-01 | 0.266 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.419650e-01 | 0.266 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.452832e-01 | 0.263 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 5.483582e-01 | 0.261 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.528057e-01 | 0.257 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.547717e-01 | 0.256 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.573933e-01 | 0.254 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.578687e-01 | 0.253 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.589985e-01 | 0.253 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.603516e-01 | 0.252 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.603516e-01 | 0.252 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.603516e-01 | 0.252 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.603516e-01 | 0.252 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.603516e-01 | 0.252 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.603516e-01 | 0.252 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.603516e-01 | 0.252 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.605360e-01 | 0.251 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.605360e-01 | 0.251 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.605360e-01 | 0.251 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.605360e-01 | 0.251 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.605360e-01 | 0.251 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.605360e-01 | 0.251 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.605360e-01 | 0.251 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.605360e-01 | 0.251 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.605360e-01 | 0.251 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.605360e-01 | 0.251 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 5.605360e-01 | 0.251 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.605360e-01 | 0.251 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.605360e-01 | 0.251 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.620932e-01 | 0.250 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.624373e-01 | 0.250 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.624373e-01 | 0.250 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.624373e-01 | 0.250 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.624373e-01 | 0.250 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.624373e-01 | 0.250 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.624373e-01 | 0.250 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 5.629618e-01 | 0.250 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.653023e-01 | 0.248 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.653023e-01 | 0.248 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.653023e-01 | 0.248 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.776919e-01 | 0.238 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.879686e-01 | 0.231 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.879686e-01 | 0.231 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.888143e-01 | 0.230 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.888143e-01 | 0.230 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.888143e-01 | 0.230 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.931442e-01 | 0.227 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.931442e-01 | 0.227 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.931442e-01 | 0.227 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.931442e-01 | 0.227 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.931442e-01 | 0.227 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.931442e-01 | 0.227 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.081678e-01 | 0.216 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.089906e-01 | 0.215 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.092494e-01 | 0.215 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.092494e-01 | 0.215 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.092494e-01 | 0.215 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.092494e-01 | 0.215 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.092494e-01 | 0.215 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.092494e-01 | 0.215 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.092494e-01 | 0.215 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.092494e-01 | 0.215 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.092494e-01 | 0.215 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.092494e-01 | 0.215 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.092494e-01 | 0.215 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.092494e-01 | 0.215 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.092494e-01 | 0.215 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.092494e-01 | 0.215 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.092494e-01 | 0.215 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.092494e-01 | 0.215 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.092494e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.099275e-01 | 0.215 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.099275e-01 | 0.215 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.141447e-01 | 0.212 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.141447e-01 | 0.212 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.208816e-01 | 0.207 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.240718e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.240718e-01 | 0.205 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.240718e-01 | 0.205 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.243887e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.244479e-01 | 0.205 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.273060e-01 | 0.203 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.384008e-01 | 0.195 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.384008e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.458228e-01 | 0.190 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.514819e-01 | 0.186 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.525656e-01 | 0.185 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.525656e-01 | 0.185 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.525656e-01 | 0.185 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.525656e-01 | 0.185 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.525656e-01 | 0.185 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.525656e-01 | 0.185 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.525656e-01 | 0.185 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.525656e-01 | 0.185 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.525656e-01 | 0.185 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.525656e-01 | 0.185 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.525656e-01 | 0.185 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.525656e-01 | 0.185 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.531448e-01 | 0.185 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.531448e-01 | 0.185 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.531448e-01 | 0.185 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.531448e-01 | 0.185 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.531448e-01 | 0.185 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.679956e-01 | 0.175 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.707193e-01 | 0.173 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.707193e-01 | 0.173 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.713076e-01 | 0.173 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.713076e-01 | 0.173 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.749487e-01 | 0.171 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.780442e-01 | 0.169 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.780442e-01 | 0.169 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.788493e-01 | 0.168 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.803943e-01 | 0.167 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.803943e-01 | 0.167 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.803943e-01 | 0.167 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.803943e-01 | 0.167 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.803943e-01 | 0.167 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.803943e-01 | 0.167 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.803943e-01 | 0.167 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.810761e-01 | 0.167 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.810761e-01 | 0.167 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.810761e-01 | 0.167 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.832268e-01 | 0.165 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.836361e-01 | 0.165 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.836361e-01 | 0.165 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.836361e-01 | 0.165 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.836361e-01 | 0.165 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.902177e-01 | 0.161 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.910822e-01 | 0.160 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.910822e-01 | 0.160 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.910822e-01 | 0.160 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.910822e-01 | 0.160 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.910822e-01 | 0.160 | 0 | 0 |
| Opsins | R-HSA-419771 | 6.910822e-01 | 0.160 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 6.910822e-01 | 0.160 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.910822e-01 | 0.160 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.910822e-01 | 0.160 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.910822e-01 | 0.160 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.910822e-01 | 0.160 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.910822e-01 | 0.160 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.995539e-01 | 0.155 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.046131e-01 | 0.152 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.046131e-01 | 0.152 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.046131e-01 | 0.152 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.058672e-01 | 0.151 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.058672e-01 | 0.151 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.058672e-01 | 0.151 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.058672e-01 | 0.151 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.058672e-01 | 0.151 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.076604e-01 | 0.150 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.083417e-01 | 0.150 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.083417e-01 | 0.150 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.094377e-01 | 0.149 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.109865e-01 | 0.148 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.133331e-01 | 0.147 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.133331e-01 | 0.147 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.138933e-01 | 0.146 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.208814e-01 | 0.142 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.245085e-01 | 0.140 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.245085e-01 | 0.140 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.253309e-01 | 0.139 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.253309e-01 | 0.139 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.253309e-01 | 0.139 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.253309e-01 | 0.139 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.253309e-01 | 0.139 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.253309e-01 | 0.139 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.253309e-01 | 0.139 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.253309e-01 | 0.139 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.253309e-01 | 0.139 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.253309e-01 | 0.139 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.253309e-01 | 0.139 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.253309e-01 | 0.139 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.253309e-01 | 0.139 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.253309e-01 | 0.139 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.253309e-01 | 0.139 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.286192e-01 | 0.137 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.293779e-01 | 0.137 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.293779e-01 | 0.137 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.296225e-01 | 0.137 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.296225e-01 | 0.137 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.296225e-01 | 0.137 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.395959e-01 | 0.131 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.422386e-01 | 0.129 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 7.433401e-01 | 0.129 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.433401e-01 | 0.129 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.442468e-01 | 0.128 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.442468e-01 | 0.128 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.517279e-01 | 0.124 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.517279e-01 | 0.124 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.517279e-01 | 0.124 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.517279e-01 | 0.124 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.517279e-01 | 0.124 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.517279e-01 | 0.124 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.517279e-01 | 0.124 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.520767e-01 | 0.124 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.557844e-01 | 0.122 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.557844e-01 | 0.122 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.557844e-01 | 0.122 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.557844e-01 | 0.122 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.557844e-01 | 0.122 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.557844e-01 | 0.122 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.557844e-01 | 0.122 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.557844e-01 | 0.122 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.557844e-01 | 0.122 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.565132e-01 | 0.121 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.580254e-01 | 0.120 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.611307e-01 | 0.119 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.611307e-01 | 0.119 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.611307e-01 | 0.119 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.721548e-01 | 0.112 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.722571e-01 | 0.112 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.722571e-01 | 0.112 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.722571e-01 | 0.112 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.722571e-01 | 0.112 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.722571e-01 | 0.112 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.730526e-01 | 0.112 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.733508e-01 | 0.112 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.772699e-01 | 0.109 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.779078e-01 | 0.109 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.779195e-01 | 0.109 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.788391e-01 | 0.109 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.828629e-01 | 0.106 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.828629e-01 | 0.106 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.828629e-01 | 0.106 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.852080e-01 | 0.105 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.912879e-01 | 0.102 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.912879e-01 | 0.102 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.937025e-01 | 0.100 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.937025e-01 | 0.100 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.937025e-01 | 0.100 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.008898e-01 | 0.096 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.069404e-01 | 0.093 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.069404e-01 | 0.093 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.069404e-01 | 0.093 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.069404e-01 | 0.093 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 8.069404e-01 | 0.093 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.069404e-01 | 0.093 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.069404e-01 | 0.093 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.069404e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.085487e-01 | 0.092 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.085487e-01 | 0.092 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.085487e-01 | 0.092 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.089000e-01 | 0.092 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.089000e-01 | 0.092 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.089000e-01 | 0.092 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.089000e-01 | 0.092 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.089000e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.095617e-01 | 0.092 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.137361e-01 | 0.090 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.137361e-01 | 0.090 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.224821e-01 | 0.085 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.224821e-01 | 0.085 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.251740e-01 | 0.083 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.251740e-01 | 0.083 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.251740e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.251740e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.258946e-01 | 0.083 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.283493e-01 | 0.082 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.283493e-01 | 0.082 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.283493e-01 | 0.082 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.283493e-01 | 0.082 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.283493e-01 | 0.082 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.283493e-01 | 0.082 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.283493e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.287037e-01 | 0.082 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.355403e-01 | 0.078 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.355403e-01 | 0.078 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.361223e-01 | 0.078 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.383663e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.401901e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.401901e-01 | 0.076 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.401901e-01 | 0.076 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.401901e-01 | 0.076 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.401901e-01 | 0.076 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.443600e-01 | 0.073 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.443600e-01 | 0.073 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.473853e-01 | 0.072 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.473853e-01 | 0.072 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.473853e-01 | 0.072 | 0 | 0 |
| Acetylation | R-HSA-156582 | 8.473853e-01 | 0.072 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.473853e-01 | 0.072 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.473853e-01 | 0.072 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.473853e-01 | 0.072 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.473853e-01 | 0.072 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.473853e-01 | 0.072 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.473853e-01 | 0.072 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.477616e-01 | 0.072 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.477616e-01 | 0.072 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.477616e-01 | 0.072 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.540271e-01 | 0.069 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.540271e-01 | 0.069 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.540271e-01 | 0.069 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.540271e-01 | 0.069 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.591849e-01 | 0.066 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.591849e-01 | 0.066 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.591849e-01 | 0.066 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.643111e-01 | 0.063 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.643111e-01 | 0.063 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.643111e-01 | 0.063 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.643111e-01 | 0.063 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.666198e-01 | 0.062 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.667616e-01 | 0.062 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.673484e-01 | 0.062 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.698492e-01 | 0.061 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.698492e-01 | 0.061 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.726874e-01 | 0.059 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.729195e-01 | 0.059 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.771731e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.771731e-01 | 0.057 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.778454e-01 | 0.057 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.784681e-01 | 0.056 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.784681e-01 | 0.056 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.784681e-01 | 0.056 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.784681e-01 | 0.056 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.784681e-01 | 0.056 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.784681e-01 | 0.056 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.793607e-01 | 0.056 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.793607e-01 | 0.056 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.793607e-01 | 0.056 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.793607e-01 | 0.056 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.793607e-01 | 0.056 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.793607e-01 | 0.056 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.793607e-01 | 0.056 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.793607e-01 | 0.056 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.797933e-01 | 0.056 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.797933e-01 | 0.056 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.805924e-01 | 0.055 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.835909e-01 | 0.054 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.836928e-01 | 0.054 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.856610e-01 | 0.053 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.892178e-01 | 0.051 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.892178e-01 | 0.051 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.915430e-01 | 0.050 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.927418e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.927418e-01 | 0.049 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.927418e-01 | 0.049 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.927418e-01 | 0.049 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.927418e-01 | 0.049 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.927418e-01 | 0.049 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.927418e-01 | 0.049 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.927418e-01 | 0.049 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.942368e-01 | 0.049 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.976734e-01 | 0.047 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.976734e-01 | 0.047 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.990789e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.990789e-01 | 0.046 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.000111e-01 | 0.046 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.016935e-01 | 0.045 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.046395e-01 | 0.044 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.046395e-01 | 0.044 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.046395e-01 | 0.044 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.046395e-01 | 0.044 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.046395e-01 | 0.044 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.046395e-01 | 0.044 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.046395e-01 | 0.044 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.046395e-01 | 0.044 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.046395e-01 | 0.044 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.056836e-01 | 0.043 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.065807e-01 | 0.043 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.081163e-01 | 0.042 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.125919e-01 | 0.040 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.127699e-01 | 0.040 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.131218e-01 | 0.039 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.131218e-01 | 0.039 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.152180e-01 | 0.038 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.152180e-01 | 0.038 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.152180e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.152180e-01 | 0.038 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.152180e-01 | 0.038 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.152180e-01 | 0.038 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.152180e-01 | 0.038 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.152180e-01 | 0.038 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.163912e-01 | 0.038 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.163912e-01 | 0.038 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.190771e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.239617e-01 | 0.034 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.239617e-01 | 0.034 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.246235e-01 | 0.034 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.246235e-01 | 0.034 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.246235e-01 | 0.034 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.246235e-01 | 0.034 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.246235e-01 | 0.034 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.246235e-01 | 0.034 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.246235e-01 | 0.034 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.256484e-01 | 0.034 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.264185e-01 | 0.033 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.264185e-01 | 0.033 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.264185e-01 | 0.033 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.267354e-01 | 0.033 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.267354e-01 | 0.033 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.323418e-01 | 0.030 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.323418e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.329862e-01 | 0.030 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.329862e-01 | 0.030 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.329862e-01 | 0.030 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.329862e-01 | 0.030 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.329862e-01 | 0.030 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.329862e-01 | 0.030 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.329862e-01 | 0.030 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.371277e-01 | 0.028 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.404214e-01 | 0.027 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.404214e-01 | 0.027 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.404214e-01 | 0.027 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.404214e-01 | 0.027 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.404214e-01 | 0.027 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.404214e-01 | 0.027 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.404214e-01 | 0.027 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.413482e-01 | 0.026 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.429733e-01 | 0.026 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.429733e-01 | 0.026 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.451210e-01 | 0.025 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.470321e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.470321e-01 | 0.024 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.470321e-01 | 0.024 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.475728e-01 | 0.023 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.482364e-01 | 0.023 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.482364e-01 | 0.023 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.502192e-01 | 0.022 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.518954e-01 | 0.021 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.529097e-01 | 0.021 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.529097e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.529097e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.529097e-01 | 0.021 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.529097e-01 | 0.021 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.530341e-01 | 0.021 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.530341e-01 | 0.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.537043e-01 | 0.021 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.539935e-01 | 0.020 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.539935e-01 | 0.020 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.540690e-01 | 0.020 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.558833e-01 | 0.020 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.570258e-01 | 0.019 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.572779e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.574048e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.574048e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.581353e-01 | 0.019 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.581353e-01 | 0.019 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.581353e-01 | 0.019 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.614904e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.627813e-01 | 0.016 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.627813e-01 | 0.016 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.627813e-01 | 0.016 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.627813e-01 | 0.016 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.629473e-01 | 0.016 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.651543e-01 | 0.015 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.669120e-01 | 0.015 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.669120e-01 | 0.015 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.669120e-01 | 0.015 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.669120e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.677814e-01 | 0.014 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.705844e-01 | 0.013 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.705844e-01 | 0.013 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.705844e-01 | 0.013 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.705844e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.738495e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.738495e-01 | 0.012 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.738495e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.759223e-01 | 0.011 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.767523e-01 | 0.010 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.767523e-01 | 0.010 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.767523e-01 | 0.010 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.767523e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.767523e-01 | 0.010 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.782494e-01 | 0.010 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.787238e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.793330e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.793330e-01 | 0.009 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.807580e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.807580e-01 | 0.008 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.811145e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.816274e-01 | 0.008 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.816274e-01 | 0.008 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.816274e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.818751e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.836672e-01 | 0.007 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.836672e-01 | 0.007 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.837914e-01 | 0.007 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.842756e-01 | 0.007 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.849000e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.854806e-01 | 0.006 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.857913e-01 | 0.006 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.858787e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.860112e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.862247e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.862247e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.870928e-01 | 0.006 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.870928e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.888679e-01 | 0.005 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.888679e-01 | 0.005 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.896653e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.898002e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.901183e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.903033e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.905218e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.909329e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.909329e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.919399e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.919399e-01 | 0.004 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.921134e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.928351e-01 | 0.003 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.928351e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.928351e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.932176e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.943385e-01 | 0.002 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.943385e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.943385e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.943385e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.943385e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.943385e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.949674e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.949988e-01 | 0.002 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.957096e-01 | 0.002 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.959395e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.960235e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.960235e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.960235e-01 | 0.002 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.963108e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.963108e-01 | 0.002 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.964653e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.966489e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.969812e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.970057e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.971624e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.974456e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.975176e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.975176e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.977934e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.977934e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.980176e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.980387e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.981009e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.985564e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.985590e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.985888e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.985961e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.986227e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.986227e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.987016e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.987758e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.988682e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.989119e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.989502e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990329e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.990562e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993843e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.994007e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.994519e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.994636e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.995537e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996068e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.996379e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.996477e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996709e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997025e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.997025e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997650e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.997686e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.997814e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997912e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998534e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998534e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998666e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998697e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999086e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999086e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999086e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999086e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999166e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999273e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999600e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999644e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999644e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999719e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999719e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999763e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999766e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999922e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999962e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999967e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999968e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999974e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999985e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999986e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999987e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999994e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999994e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999995e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999995e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |